symptoms,diagnosis,GPT4o top 10,GPT4o top 20,GPT4o match top 10,GPT4o match top 20,Claude top 10,Claude top 20,Claude match top 10,Claude match top 20
Slowing of speech; Impaired occupational functioning; Irritability; Aphasic symptoms; Transient episodes of disorientation; Cognitive decline; Apraxia; Acalculia; Ataxia; Bradykinesia,ALZHEIMER DISEASE 3; AD3,"alzheimer disease,frontotemporal dementia,progressive supranuclear palsy 1; psp1,corticobasal degeneration,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 17; sca17","alzheimer disease, familial, 1,alzheimer disease, familial, 3,alzheimer disease, familial, 4,alzheimer disease, familial, 5,alzheimer disease, familial, 6,alzheimer disease, familial, 7,alzheimer disease, familial, 8,alzheimer disease, familial, 9,alzheimer disease, familial, 10,alzheimer disease, familial, 11,alzheimer disease, familial, 12,alzheimer disease, familial, 13,alzheimer disease, familial, 14,alzheimer disease, familial, 15,alzheimer disease, familial, 16,alzheimer disease, familial, 17,alzheimer disease, familial, 18,alzheimer disease, familial, 19,alzheimer disease, familial, 20,alzheimer disease, familial, 21",1,0,"frontotemporal dementia; ftd,spinocerebellar ataxia 1; sca1,huntington disease; hd,alzheimer disease, early-onset; eoad,corticobasal degeneration; cbd,progressive supranuclear palsy 1; psp1,niemann-pick disease, type c1; npc1,wilson disease; wnd,adult-onset alexander disease; alxd,neurodegeneration with brain iron accumulation 1; nbia1","frontotemporal dementia; ftd,alzheimer disease, early-onset; eoad,spinocerebellar ataxia 1; sca1,huntington disease; hd,spinocerebellar ataxia 2; sca2,corticobasal degeneration; cbd,progressive supranuclear palsy 1; psp1,spinocerebellar ataxia 3; sca3,niemann-pick disease, type c1; npc1,wilson disease; wnd,cerebrotendinous xanthomatosis; ctx,adult-onset alexander disease; alxd,neurodegeneration with brain iron accumulation 1; nbia1,kufor-rakeb syndrome; krs,spinocerebellar ataxia 6; sca6,dentatorubral-pallidoluysian atrophy; drpla,neuronal ceroid lipofuscinosis 4b; cln4b,mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes; melas,spinocerebellar ataxia 7; sca7,niemann-pick disease, type c2; npc2",0,0
Epilepsy; Macrocephaly; Psychomotor retardation; Muscle weakness; Spasticity; Bulbar symptoms; Atonic seizures,ALEXANDER DISEASE; ALXDRD,"megalencephaly-capillary malformation-polymicrogyria syndrome; mcap,tuberous sclerosis 1; tsc1,tuberous sclerosis 2; tsc2,megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1; mpph1,alpha-thalassemia/mental retardation syndrome, x-linked; atrx,lissencephaly 1; lis1,lissencephaly 2; lis2,spinal muscular atrophy, type i; sma1,spinal muscular atrophy, type ii; sma2,spinal muscular atrophy, type iii; sma3","megalencephaly-capillary malformation-polymicrogyria syndrome; mcap,megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1; mpph1,epilepsy, focal, with speech disorder and with or without mental retardation; fesd,epilepsy, familial temporal lobe, 1; etl1,epilepsy, generalized, with febrile seizures plus, type 1; egfsp1,epilepsy, myoclonic-atonic; ema,epilepsy, progressive myoclonic 1a; epm1a,epilepsy, severe myoclonic, in infancy; smei,epilepsy, generalized, with febrile seizures plus, type 2; egfsp2,epilepsy, generalized, with febrile seizures plus, type 3; egfsp3,epilepsy, generalized, with febrile seizures plus, type 4; egfsp4,epilepsy, generalized, with febrile seizures plus, type 5; egfsp5,epilepsy, generalized, with febrile seizures plus, type 6; egfsp6,epilepsy, generalized, with febrile seizures plus, type 7; egfsp7,epilepsy, generalized, with febrile seizures plus, type 8; egfsp8,epilepsy, generalized, with febrile seizures plus, type 9; egfsp9,epilepsy, generalized, with febrile seizures plus, type 10; egfsp10,epilepsy, generalized, with febrile seizures plus, type 11; egfsp11,epilepsy, generalized, with febrile seizures plus, type 12; egfsp12,epilepsy, generalized, with febrile seizures plus, type 13; egfsp13",0,0,"epileptic encephalopathy, early infantile, 4; eiee4,megalencephalic leukoencephalopathy with subcortical cysts 1; mlc1,spastic paraplegia 35, autosomal recessive; spg35,epileptic encephalopathy, early infantile, 6; eiee6,neurodegeneration with brain iron accumulation 1; nbia1,pontocerebellar hypoplasia, type 6; pch6,progressive epilepsy-intellectual disability syndrome; peid,spastic paraplegia 11, autosomal recessive; spg11,megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome; mpph,epileptic encephalopathy, early infantile, 25; eiee25","epileptic encephalopathy, early infantile, 4; eiee4,megalencephalic leukoencephalopathy with subcortical cysts 1; mlc1,epileptic encephalopathy, early infantile, 6; eiee6,spastic paraplegia 35, autosomal recessive; spg35,progressive epilepsy-intellectual disability syndrome,epileptic encephalopathy, early infantile, 25; eiee25,neurodegeneration with brain iron accumulation 1; nbia1,spastic paraplegia 11, autosomal recessive; spg11,ceroid lipofuscinosis, neuronal, 2; cln2,alexander disease; alxdrd,canavan disease; aspa,mitochondrial dna depletion syndrome 5; mtdps5,epileptic encephalopathy, early infantile, 14; eiee14,spastic paraplegia 50, autosomal recessive; spg50,megalencephalic leukoencephalopathy with subcortical cysts 2a; mlc2a,leigh syndrome; ls,epileptic encephalopathy, early infantile, 31; eiee31,spastic paraplegia 4, autosomal dominant; spg4,neurodegeneration with brain iron accumulation 2a; nbia2a,aicardi-goutieres syndrome 1; ags1",0,1
Progressive external ophthalmoplegia; Pigmentary retinopathy; Cardiac conduction anomalies; Sensorineural hearing loss; Cerebellar ataxia; Muscle weakness; Nystagmus; Ptosis; Tremor; Exercise intolerance,KEARNS-SAYRE SYNDROME; KSS,"kearns-sayre syndrome,mitochondrial dna depletion syndrome 4a (mngie type),spinocerebellar ataxia 36; sca36,spinocerebellar ataxia 28; sca28,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 8; sca8,spinocerebellar ataxia 10; sca10","kearns-sayre syndrome,mitochondrial dna depletion syndrome 4a (mngie type); mtdps4a,mitochondrial dna depletion syndrome 4b (mngie type); mtdps4b,spinocerebellar ataxia 28; sca28,spinocerebellar ataxia 36; sca36,spinocerebellar ataxia 38; sca38,spinocerebellar ataxia 39; sca39,spinocerebellar ataxia 40; sca40,spinocerebellar ataxia 41; sca41,spinocerebellar ataxia 42; sca42,spinocerebellar ataxia 43; sca43,spinocerebellar ataxia 44; sca44,spinocerebellar ataxia 45; sca45,spinocerebellar ataxia 46; sca46,spinocerebellar ataxia 47; sca47,spinocerebellar ataxia 48; sca48,spinocerebellar ataxia 49; sca49,spinocerebellar ataxia 50; sca50,spinocerebellar ataxia 51; sca51,spinocerebellar ataxia 52; sca52",1,1,"progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 1; peoa1,mitochondrial dna depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria); mtdps5,kearns-sayre syndrome; kss,mitochondrial recessive ataxia syndrome; miras,spinocerebellar ataxia with axonal neuropathy 2; scan2,mitochondrial dna depletion syndrome 7 (hepatocerebral type); mtdps7,ophthalmoplegia, external, with ragged red fibers; cpeo,mitochondrial myopathy and sideroblastic anemia 1; mlasa1,sensory ataxic neuropathy, dysarthria, and ophthalmoparesis; sando,mitochondrial dna depletion syndrome 4b (mngie type); mtdps4b","progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 1; peoa1,mitochondrial dna depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria); mtdps5,kearns-sayre syndrome; kss,mitochondrial dna depletion syndrome 7 (hepatocerebral type); mtdps7,progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 2; peoa2,mitochondrial complex i deficiency, nuclear type 12; mc1dn12,spinocerebellar ataxia 28; sca28,mitochondrial recessive ataxia syndrome; miras,optic atrophy plus syndrome; opa+,mitochondrial dna depletion syndrome 4b (mngie type); mtdps4b,coenzyme q10 deficiency, primary, 4; coq10d4,mitochondrial myopathy and sideroblastic anemia 1; mlasa1,sando syndrome,narp syndrome,leigh syndrome; ls,mitochondrial complex iii deficiency, nuclear type 2; mc3dn2,progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 3; peoa3,mitochondrial dna depletion syndrome 8a (encephalomyopathic type); mtdps8a,spinocerebellar ataxia, autosomal recessive 1; scar1,mitochondrial neurogastrointestinal enc",1,1
Muscle cramps; Easy fatigability; Muscle weakness; Muscle hypertrophy; Myokymia; Frequent falls; Elevated serum creatine kinase,Episodic ataxia 8,"myotonic dystrophy 1,myotonic dystrophy 2,hypertrophic cardiomyopathy, familial, 1; cmh1,hypertrophic cardiomyopathy, familial, 2; cmh2,hypertrophic cardiomyopathy, familial, 3; cmh3,hypertrophic cardiomyopathy, familial, 4; cmh4,hypertrophic cardiomyopathy, familial, 5; cmh5,hypertrophic cardiomyopathy, familial, 6; cmh6,hypertrophic cardiomyopathy, familial, 7; cmh7,hypertrophic cardiomyopathy, familial, 8; cmh8","myotonic dystrophy 1,myotonic dystrophy 2,hyperkalemic periodic paralysis,paramyotonia congenita of von euler,brody myopathy,central core disease of muscle,carnitine palmitoyltransferase ii deficiency, muscle,glycogen storage disease v; gsd5,glycogen storage disease vii; gsd7,ryr1-related myopathy,dystrophinopathy,bethlem myopathy 1,bethlem myopathy 2,bethlem myopathy 3,congenital myasthenic syndrome 1a,congenital myasthenic syndrome 1b,congenital myasthenic syndrome 2a,congenital myasthenic syndrome 2c,congenital myasthenic syndrome 3a,congenital myasthenic syndrome 4a",0,0,"isaacs syndrome; isacs,rippling muscle disease 2; rmd2,neuromyotonia and axonal neuropathy, autosomal dominant,schwartz-jampel syndrome, type 1; sjs1,myotonia congenita, autosomal dominant; mc,paramyotonia congenita; pmc,myotonia congenita, autosomal recessive,potassium-aggravated myotonia; pam,hyperkalemic periodic paralysis, type 1; hypp1,myopathy, proximal, and ophthalmoplegia; pmyo","rippling muscle disease 2; rmd2,isaacs syndrome; isacs,myotonia congenita, autosomal dominant; mc,neuromyotonia and axonal neuropathy 2; nman2,myotonia congenita, autosomal recessive; myot2,schwartz-jampel syndrome, type 1; sjs1,paramyotonia congenita of von eulenburg; pmc,potassium-aggravated myotonia; pam,myotonic dystrophy 1; dm1,myotonic dystrophy 2; dm2,neuromyotonia and axonal neuropathy 1; nman1,hyperkalemic periodic paralysis, type 1; hypp1,myopathy, proximal, and ophthalmoplegia; mpop,rippling muscle disease 1; rmd1,myopathy, distal, with rimmed vacuoles; dmrv,muscular dystrophy-dystroglycanopathy type a1; mddga1,myasthenic syndrome, congenital, 1a; cms1a,myopathy, myofibrillar, 1; mfm1,muscular dystrophy, limb-girdle, type 2b; lgmd2b,myopathy, distal, 1; mpd1",0,0
Spasticity; Dystonia; Loss of developmental milestones; Fever; Cough; Coryza,Vanishing White Matter Disease,"dystonia 1, torsion, autosomal dominant; dyt1,spastic paraplegia 3a, autosomal dominant; spg3a,spastic paraplegia 4, autosomal dominant; spg4,dystonia 6, torsion; dyt6,spastic paraplegia 11, autosomal recessive; spg11,dystonia 12, torsion; dyt12,spastic paraplegia 7, autosomal recessive; spg7,dystonia 5, torsion, autosomal recessive; dyt5,spastic paraplegia 2, x-linked; spg2,dystonia 16, torsion; dyt16","dystonia 1, torsion, autosomal dominant; dyt1,dystonia 6, torsion; dyt6,dystonia 12; dyt12,dystonia 16, torsion; dyt16,dystonia 28; dyt28,spastic paraplegia 4, autosomal dominant; spg4,spastic paraplegia 3a, autosomal dominant; spg3a,spastic paraplegia 7, autosomal recessive; spg7,spastic paraplegia 11, autosomal recessive; spg11,spastic paraplegia 15, autosomal recessive; spg15,spastic paraplegia 20, autosomal recessive; spg20,spastic paraplegia 31, autosomal dominant; spg31,spastic paraplegia 35, autosomal recessive; spg35,spastic paraplegia 46, autosomal recessive; spg46,spastic paraplegia 50, autosomal recessive; spg50,spastic paraplegia 56, autosomal recessive; spg56,spastic paraplegia 58, autosomal recessive; spg58,spastic paraplegia 76, autosomal recessive; spg76,spastic paraplegia 78, autosomal recessive; spg78,spastic paraplegia 83, autosomal recessive; spg83",0,0,"leigh syndrome,neurodegeneration with brain iron accumulation 1; nbia1,mitochondrial dna depletion syndrome 5; mtdps5,spastic paraplegia 35; spg35,glutaric acidemia i; ga1,metachromatic leukodystrophy; mld,neurodegeneration due to cerebral folate transport deficiency,pelizaeus-merzbacher disease; pmd,infantile neuroaxonal dystrophy 1; inad1,alexander disease; alxdrd","leigh syndrome,neurodegeneration with brain iron accumulation 1; nbia1,spastic paraplegia 4, autosomal dominant; spg4,mitochondrial dna depletion syndrome 13; mtdps13,glutaric acidemia i; ga1,leukodystrophy, hypomyelinating, 2; hld2,neurodegeneration due to cerebral folate transport deficiency,spastic paraplegia 3a, autosomal dominant; spg3a,aicardi-goutieres syndrome 1; ags1,mitochondrial complex iii deficiency, nuclear type 1; mc3dn1,pyruvate dehydrogenase e1-alpha deficiency,leukodystrophy, metachromatic; mld,pelizaeus-merzbacher disease; pmd,mitochondrial complex i deficiency, nuclear type 1,krabbe disease,alexander disease; alxdrd,canavan disease,niemann-pick disease, type c1; npc1,pantothenate kinase-associated neurodegeneration; pkan,ceroid lipofuscinosis, neuronal, 2; cln2",0,0
Delayed motor development; Congenital nystagmus; Ataxic gait; Kyphosis; Scoliosis; Dysarthria; Difficulty swallowing; Absent lower limb tendon reflexes; Neuropathic pain,Charcot-Marie-Tooth disease type 4J,"friedreich ataxia,spinocerebellar ataxia 3; sca3,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 17; sca17,spinocerebellar ataxia 8; sca8,spinocerebellar ataxia 10; sca10,spinocerebellar ataxia 14; sca14","friedreich ataxia,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 17; sca17,ataxia-telangiectasia,charcot-marie-tooth disease, type 2a1; cmt2a1,charcot-marie-tooth disease, type 2b1; cmt2b1,charcot-marie-tooth disease, type 4b1; cmt4b1,charcot-marie-tooth disease, type 4b2; cmt4b2,charcot-marie-tooth disease, type 4c; cmt4c,charcot-marie-tooth disease, type 4d; cmt4d,charcot-marie-tooth disease, type 4e; cmt4e,charcot-marie-tooth disease, type 4f; cmt4f,charcot-marie-tooth disease, type 4g; cmt4g,charcot-marie-tooth disease, type 4h; cmt4h,charcot-marie-tooth disease, type 4j; cmt4j,charcot-marie-tooth disease, type 4k; cmt4k",0,1,"friedreich ataxia 1; frda1,spinocerebellar ataxia 1; sca1,ataxia-telangiectasia; at,charcot-marie-tooth disease, type 1a; cmt1a,spinal muscular atrophy, type 2; sma2,hereditary sensory and autonomic neuropathy type 1; hsan1,spinocerebellar ataxia 2; sca2,ataxia with vitamin e deficiency; aved,marinesco-sjogren syndrome; mss,hereditary motor and sensory neuropathy, type iib; hmsn2b","friedreich ataxia 1; frda,spinocerebellar ataxia 1; sca1,ataxia-telangiectasia; at,charcot-marie-tooth disease, type 1a; cmt1a,spinocerebellar ataxia 2; sca2,hereditary sensory and autonomic neuropathy type 1; hsan1,spastic paraplegia 7, autosomal recessive; spg7,ataxia with vitamin e deficiency; aved,marinesco-sjogren syndrome; mss,spinocerebellar ataxia 3; sca3,charcot-marie-tooth disease, type 2a1; cmt2a1,spastic ataxia 1, autosomal recessive; spax1,cerebellar ataxia, deafness, and narcolepsy, autosomal dominant; adcadn,hereditary motor and sensory neuropathy, type iib; hmsn2b,spinocerebellar ataxia 7; sca7,ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia; eaoh,spastic paraplegia 15, autosomal recessive; spg15,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1; camrq1,hereditary sensory and autonomic neuropathy type 2; hsan2,spinocerebellar ataxia 6; sca6",0,0
Global developmental delay; Apnea; Febrile seizures; Autism spectrum disorder; Gait apraxia; Stereotypic hand movements; Loss of acquired purposeful hand skills; Severe expressive and receptive language impairment; Severe intellectual disability,RETT SYNDROME; RTT,"rett syndrome,mecp2 duplication syndrome,foxg1 syndrome,cdkl5 deficiency disorder,angelman syndrome,pitt-hopkins syndrome,syngap1-related intellectual disability,dravet syndrome,stxbp1 encephalopathy,sotos syndrome","rett syndrome,angelman syndrome,mecp2 duplication syndrome,foxg1 syndrome,cdkl5 deficiency disorder,pitt-hopkins syndrome,syngap1-related intellectual disability,dravet syndrome,phelps syndrome,stxbp1 encephalopathy,sotos syndrome 1,mowat-wilson syndrome,smith-magenis syndrome,tuberous sclerosis 1,tuberous sclerosis 2,fragile x syndrome,prader-willi syndrome,williams-beuren syndrome,rubinstein-taybi syndrome 1,cohen syndrome",1,1,"rett syndrome; rtt,mental retardation, autosomal recessive 54; mrt54,epileptic encephalopathy, early infantile, 2; eiee2,pitt-hopkins syndrome; pths,angelman syndrome; as,mental retardation, autosomal dominant 50; mrd50,epileptic encephalopathy, early infantile, 4; eiee4,christianson syndrome; csnk,mental retardation, x-linked, syndromic, nascimento type; mrxsn,developmental and epileptic encephalopathy 51; dee51","rett syndrome; rtt,mental retardation, autosomal recessive 1; mrt1,epileptic encephalopathy, early infantile, 2; eiee2,angelman syndrome; as,pitt-hopkins syndrome; pths,mental retardation, autosomal dominant 5; mrd5,epileptic encephalopathy, early infantile, 4; eiee4,christianson syndrome; csnk,mental retardation, x-linked 1; mrx1,epileptic encephalopathy, early infantile, 6; eiee6,mental retardation, autosomal recessive 3; mrt3,developmental and epileptic encephalopathy 51; dee51,autism, susceptibility to, 1; auts1,mental retardation, x-linked, syndromic, nascimento type; mrxsn,developmental and epileptic encephalopathy 28; dee28,mental retardation, autosomal dominant 54; mrd54,epileptic encephalopathy, early infantile, 9; eiee9,mental retardation, x-linked 30; mrx30,developmental and epileptic encephalopathy 14; dee14,mental retardation, autosomal recessive 13; mrt13",1,1
Speech and language delay; Aggressive behavior; Self-injurious behavior; Stereotypic movement; Sleep disturbance; Attention deficit hyperactivity disorder; Intellectual disability; Seizures; Catatonia,"PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA","fragile x syndrome,rett syndrome,angelman syndrome,smith-magenis syndrome,phelan-mcdermid syndrome,prader-willi syndrome,tuberous sclerosis 1,lesch-nyhan syndrome,sanfilippo syndrome a,mowat-wilson syndrome","fragile x syndrome,rett syndrome,angelman syndrome,smith-magenis syndrome,prader-willi syndrome,tuberous sclerosis 1; tsc1,tuberous sclerosis 2; tsc2,lesch-nyhan syndrome,pitt-hopkins syndrome,sanfilippo syndrome a; mps3a,sanfilippo syndrome b; mps3b,sanfilippo syndrome c; mps3c,sanfilippo syndrome d; mps3d,smith-lemli-opitz syndrome,mowat-wilson syndrome,syngap1-related intellectual disability,foxg1 syndrome,cdkl5 deficiency disorder,mecp2 duplication syndrome,phelan-mcdermid syndrome",0,0,"autism, susceptibility to, 1; auts1,mental retardation, autosomal dominant 54; mrd54,epileptic encephalopathy, early infantile, 4; eiee4,mental retardation, autosomal recessive 62; mrt62,rett syndrome; rtt,phelan-mcdermid syndrome; phmds,angelman syndrome; as,mental retardation, x-linked, syndromic, christianson type; mrxsch,epileptic encephalopathy, early infantile, 2; eiee2,mental retardation, x-linked 102; mrx102","mental retardation, autosomal dominant 54; mrd54,epileptic encephalopathy, early infantile, 4; eiee4,mental retardation, autosomal recessive 62; mrt62,rett syndrome; rtt,angelman syndrome; as,phelan-mcdermid syndrome; phmds,mental retardation, x-linked 102; mrx102,autism, susceptibility to, 18; auts18,epileptic encephalopathy, early infantile, 6; eiee6,mental retardation, autosomal dominant 51; mrd51,christianson syndrome; csnk,mental retardation, x-linked, syndromic, nascimento type; mrxsn,epileptic encephalopathy, early infantile, 9; eiee9,mental retardation, autosomal recessive 47; mrt47,kleefstra syndrome 1; ks1,mental retardation, x-linked 98; mrx98,epileptic encephalopathy, early infantile, 2; eiee2,mental retardation, autosomal dominant 23; mrd23,dravet syndrome; drvt,mental retardation, x-linked 30; mrx30",0,0
Dysarthria; Dystonia; Tremor; Choreoathetosis; Parkinsonism; Ataxia; Seizures; Kayser-Fleischer rings; Cognitive impairment; Abnormal gait,Wilson's disease,"wilson disease,neurodegeneration with brain iron accumulation 1; nbia1,dentatorubral-pallidoluysian atrophy; drpla,huntington disease,parkinson disease 1; park1,spinocerebellar ataxia 3; sca3,neuroferritinopathy,glutaric aciduria i; ga1,friedreich ataxia; frda,ataxia-telangiectasia; a-t","wilson disease,neurodegeneration with brain iron accumulation 1; nbia1,dentatorubral-pallidoluysian atrophy; drpla,huntington disease,parkinson disease 1; park1,spinocerebellar ataxia 3; sca3,friedreich ataxia,neuroferritinopathy,glutaric aciduria i,ataxia-telangiectasia,dopa-responsive dystonia,mitochondrial dna depletion syndrome 1 (mngie type); mtdps1,leigh syndrome,neuronal ceroid lipofuscinosis 1; cln1,gaucher disease, type 3,alpha-mannosidosis,niemann-pick disease, type c1,ataxia with oculomotor apraxia type 1; aoa1,spinocerebellar ataxia 2; sca2,juvenile parkinsonism",0,0,"wilson disease; wd,neurodegeneration with brain iron accumulation 1; nbia1,dystonia-parkinsonism, young-onset; dytp,spinocerebellar ataxia 3; sca3,huntington disease; hd,neuronal ceroid lipofuscinosis 3; cln3,niemann-pick disease, type c1; npc1,ataxia-telangiectasia; at,kufor-rakeb syndrome; krs,dystonia 16; dyt16","wilson disease,neurodegeneration with brain iron accumulation 1; nbia1,dystonia 12; dyt12,spinocerebellar ataxia 2; sca2,huntington disease; hd,neurodegeneration with brain iron accumulation 2a; nbia2a,dystonia 1, torsion; dyt1,ataxia-telangiectasia; at,niemann-pick disease, type c1; npc1,spinocerebellar ataxia 3; sca3,kufor-rakeb syndrome; krs,neuronal ceroid lipofuscinosis 3; cln3,dystonia-parkinsonism, young-onset; dytp,leigh syndrome; ls,mitochondrial encephalopathy with lactic acidosis and stroke-like episodes; melas,pantothenate kinase-associated neurodegeneration; pkan,spinocerebellar ataxia 17; sca17,glutaric acidemia i; ga1,machado-joseph disease; mjd,neurodegeneration with brain iron accumulation 4; nbia4",0,0
Cerebellar ataxia; Parkinsonism; Dysarthria; Bradykinesia; Postural instability; Vertical gaze paresis; Neck dystonia; Cogwheel rigidity; Masked face,SPINOCEREBELLAR ATAXIA 48; SCA48,"progressive supranuclear palsy 1; psp1,spinocerebellar ataxia 3; sca3,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 17; sca17,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 8; sca8,spinocerebellar ataxia 12; sca12,spinocerebellar ataxia 14; sca14","spinocerebellar ataxia 3; sca3,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 17; sca17,spinocerebellar ataxia 8; sca8,spinocerebellar ataxia 10; sca10,spinocerebellar ataxia 12; sca12,spinocerebellar ataxia 13; sca13,spinocerebellar ataxia 14; sca14,spinocerebellar ataxia 15; sca15,spinocerebellar ataxia 16; sca16,spinocerebellar ataxia 19; sca19,spinocerebellar ataxia 21; sca21,spinocerebellar ataxia 23; sca23,spinocerebellar ataxia 27; sca27,spinocerebellar ataxia 28; sca28,spinocerebellar ataxia 29; sca29,spinocerebellar ataxia 36; sca36",1,1,"niemann-pick disease, type c1; npc1,spinocerebellar ataxia 2; sca2,progressive supranuclear palsy 1; ppnd,kufor-rakeb syndrome; krs,neurodegeneration with brain iron accumulation 1; nbia1,spinocerebellar ataxia 3; sca3,perry syndrome,mitochondrial recessive ataxia syndrome; miras,machado-joseph disease; mjd,ataxia-telangiectasia; at","niemann-pick disease, type c1; npc1,spinocerebellar ataxia 2; sca2,progressive supranuclear palsy 1; ppsp1,neurodegeneration with brain iron accumulation 1; nbia1,kufor-rakeb syndrome; krs,machado-joseph disease; mjd,spinocerebellar ataxia 3; sca3,perry syndrome,neurodegeneration with brain iron accumulation 2a; nbia2a,mitochondrial recessive ataxia syndrome; miras,spinocerebellar ataxia 17; sca17,gaucher disease, type 3; gd3,cerebrotendinous xanthomatosis; ctx,ataxia-telangiectasia; at,spinocerebellar ataxia 1; sca1,wilson disease; wnd,frontotemporal dementia and parkinsonism-17; ftdp-17,neurodegeneration with brain iron accumulation 3; nbia3,spinocerebellar ataxia 6; sca6,ataxia with oculomotor apraxia 1; aoa1",1,1
Seizures; Developmental regression; Microcephaly; Optic atrophy; Visual impairment; Auditory impairment; Spastic quadriparesis; Intracranial calcifications; Cerebral atrophy; White matter loss,NRROS-related microgliopathy,"aicardi-goutieres syndrome 1; ags1,cockayne syndrome b; csb,leigh syndrome, french-canadian type,mitochondrial dna depletion syndrome 12a (hepatic); mtdps12a,pelizaeus-merzbacher disease; pmd,pontocerebellar hypoplasia, type 1a; pch1a,rett syndrome; rtt,tay-sachs disease,wolfram syndrome 1; wfs1,zellweger syndrome spectrum; zss","aicardi-goutieres syndrome 1; ags1,cockayne syndrome b; csb,leigh syndrome, french-canadian type,mitochondrial dna depletion syndrome 1 (mngie type); mtdps1,pelizaeus-merzbacher disease; pmd,zellweger syndrome,alper's syndrome,cohen syndrome,wolfram syndrome 1; wfs1,mecp2 duplication syndrome,pontocerebellar hypoplasia, type 1a; pch1a,neuronal ceroid lipofuscinosis 2; cln2,spinocerebellar ataxia, autosomal recessive 1; scar1,mitochondrial complex i deficiency, nuclear type 1; mc1dn1,leber hereditary optic neuropathy; lhon,spinal muscular atrophy with progressive myoclonic epilepsy; sma-pme,tay-sachs disease,krabbe disease,canavan disease,coenzyme q10 deficiency, primary, 4; coq10d4",0,0,"aicardi-goutieres syndrome 1; ags1,progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy; peho,neurodegeneration with brain iron accumulation 1; nbia1,cockayne syndrome type a; csa,mitochondrial dna depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria); mtdps5,pontocerebellar hypoplasia, type 6; pch6,neurodegeneration due to cerebral folate transport deficiency; cefortd,krabbe disease; kd,alexander disease; alxdrd,infantile neuroaxonal dystrophy 1; inad1","aicardi-goutieres syndrome 1; ags1,neurodegeneration with brain iron accumulation 1; nbia1,progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy; peho,cockayne syndrome type a; csa,neuronal ceroid lipofuscinosis 1; cln1,neuronal ceroid lipofuscinosis 2; cln2,alexander disease; alxdrd,krabbe disease; kd,canavan disease; cd,mitochondrial dna depletion syndrome 5; mtdps5,rett syndrome; rtt,alpers-huttenlocher syndrome; ahs,pontocerebellar hypoplasia type 2a; pch2a,leigh syndrome; ls,infantile neuroaxonal dystrophy 1; inad1,megalencephalic leukoencephalopathy with subcortical cysts 1; mlc1,peroxisome biogenesis disorder 1a; pbd1a,trichopoliodystrophy; tpdy,mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes; melas,progressive cerebral atrophy with microcephaly and seizures; pcams",0,0
Growth retardation; Ataxia; Ocular telangiectasia; Cerebellar atrophy; Elevated serum alpha-fetoprotein,ATAXIA-TELANGIECTASIA; AT,"ataxia-telangiectasia,ataxia-telangiectasia-like disorder 1,ataxia-telangiectasia-like disorder 2,ataxia-telangiectasia-like disorder 3,ataxia-telangiectasia-like disorder 4,ataxia-telangiectasia-like disorder 5,ataxia-telangiectasia-like disorder 6,ataxia-telangiectasia-like disorder 7,ataxia-telangiectasia-like disorder 8,ataxia-telangiectasia-like disorder 9","ataxia-telangiectasia,ataxia-telangiectasia-like disorder,ataxia, cerebellar, with ocular motor apraxia,ataxia, cerebellar, with ocular motor apraxia 2,ataxia, cerebellar, with ocular motor apraxia 3,ataxia, cerebellar, with ocular motor apraxia 4,ataxia, cerebellar, with ocular motor apraxia 5,ataxia, cerebellar, with ocular motor apraxia 6,ataxia, cerebellar, with ocular motor apraxia 7,ataxia, cerebellar, with ocular motor apraxia 8,ataxia, cerebellar, with ocular motor apraxia 9,ataxia, cerebellar, with ocular motor apraxia 10,ataxia, cerebellar, with ocular motor apraxia 11,ataxia, cerebellar, with ocular motor apraxia 12,ataxia, cerebellar, with ocular motor apraxia 13,ataxia, cerebellar, with ocular motor apraxia 14,ataxia, cerebellar, with ocular motor apraxia 15,ataxia, cerebellar, with ocular motor apraxia 16,ataxia, cerebellar, with ocular motor apraxia 17,ataxia, cerebellar, with ocular motor apraxia 18",1,1,"ataxia-telangiectasia; at,ataxia-telangiectasia-like disorder 1; atld1,ataxia-telangiectasia-like disorder 2; atld2,cerebellar ataxia, neuropathy, and vestibular areflexia syndrome; canvas,spinocerebellar ataxia, autosomal recessive 9; scar9,ataxia with oculomotor apraxia 1; aoa1,ataxia with oculomotor apraxia 2; aoa2,ataxia with oculomotor apraxia 4; aoa4,cerebellar ataxia and hypogonadotropic hypogonadism; cahh,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1; camrq1","ataxia-telangiectasia; at,ataxia-telangiectasia-like disorder 1; atld1,ataxia-telangiectasia-like disorder 2; atld2,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1; camrq1,spinocerebellar ataxia, autosomal recessive 7; scar7,ataxia with oculomotor apraxia 1; aoa1,ataxia with oculomotor apraxia 2; aoa2,ataxia with oculomotor apraxia 4; aoa4,cerebellar ataxia and hypogonadotropic hypogonadism; cahh,spinocerebellar ataxia, autosomal recessive 8; scar8,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2; camrq2,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3; camrq3,nijmegen breakage syndrome; nbs,marinesco-sjogren syndrome; mss,sando syndrome,mcsz syndrome,cerebellar ataxia-pancytopenia syndrome,ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia; eaoh,spinocerebellar ataxia with axonal neuropathy 2; scan2,cerebellar ataxia and cancer syndrome",1,1
Memory impairment; Emotional instability; Horizontal nystagmus; Decreased tendon reflexes; Polyneuropathy,METACHROMATIC LEUKODYSTROPHY; MLD,"spinocerebellar ataxia type 3; sca3,charcot-marie-tooth disease, type 1a; cmt1a,friedreich ataxia; frda,spinocerebellar ataxia type 2; sca2,charcot-marie-tooth disease, type 2a1; cmt2a1,spinocerebellar ataxia type 1; sca1,spinocerebellar ataxia type 6; sca6,spinocerebellar ataxia type 7; sca7,spinocerebellar ataxia type 17; sca17,charcot-marie-tooth disease, type 4a; cmt4a","spinocerebellar ataxia 3; sca3,charcot-marie-tooth disease, type 1a; cmt1a,charcot-marie-tooth disease, type 2a1; cmt2a1,charcot-marie-tooth disease, type 2e; cmt2e,charcot-marie-tooth disease, type 4a; cmt4a,charcot-marie-tooth disease, type 4b1; cmt4b1,charcot-marie-tooth disease, type 4c; cmt4c,charcot-marie-tooth disease, type 4d; cmt4d,charcot-marie-tooth disease, type 4e; cmt4e,charcot-marie-tooth disease, type 4f; cmt4f,charcot-marie-tooth disease, type 4h; cmt4h,charcot-marie-tooth disease, type 4j; cmt4j,charcot-marie-tooth disease, type 4k; cmt4k,charcot-marie-tooth disease, type 4l; cmt4l,charcot-marie-tooth disease, type 4n; cmt4n,charcot-marie-tooth disease, type 4r; cmt4r,charcot-marie-tooth disease, type 4s; cmt4s,charcot-marie-tooth disease, type 4t; cmt4t,charcot-marie-tooth disease, type 4u; cmt4u,charcot-marie-tooth disease, type 4v; cmt4v",0,0,"spinocerebellar ataxia 1; sca1,friedreich ataxia; frda,charcot-marie-tooth disease, type 1a; cmt1a,spinocerebellar ataxia 2; sca2,machado-joseph disease; mjd,hereditary sensory and autonomic neuropathy type 1; hsan1,neurodegeneration with brain iron accumulation 1; nbia1,cerebellar ataxia, neuropathy, and vestibular areflexia syndrome; canvas,spinocerebellar ataxia 3; sca3,hereditary neuralgic amyotrophy; hna","spinocerebellar ataxia 1; sca1,charcot-marie-tooth disease, type 1a; cmt1a,spinocerebellar ataxia 2; sca2,friedreich ataxia; frda,hereditary sensory and autonomic neuropathy type 1; hsan1,spinocerebellar ataxia 3; sca3,multiple system atrophy 1; msa1,cerebellar ataxia, neuropathy, and vestibular areflexia syndrome; canvas,neurodegeneration with brain iron accumulation 1; nbia1,spinocerebellar ataxia 6; sca6,hereditary neuralgic amyotrophy; hna,ataxia-telangiectasia; at,spinocerebellar ataxia 7; sca7,charcot-marie-tooth disease, type 1b; cmt1b,machado-joseph disease; mjd,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1; camrq1,hereditary motor and sensory neuropathy type ii; hmsn2,spinocerebellar ataxia 8; sca8,polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract; pharc,cerebellar ataxia and hypogonadotropic hypogonadism; cahh",0,0
Speech delay; Epileptic seizures; Abnormal gait; Hypotonia; Tremor; Ataxia; Intellectual disability; Neurodevelopmental disorder; Dystonia,Epilepsy,"angelman syndrome,rett syndrome,dravet syndrome,fragile x syndrome,pitt-hopkins syndrome,joubert syndrome 1,spinocerebellar ataxia, autosomal recessive 10; scar10,alpha-thalassemia/mental retardation syndrome, x-linked; atrx,williams-beuren syndrome,tuberous sclerosis 1","angelman syndrome,rett syndrome,dravet syndrome,fragile x syndrome,tuberous sclerosis,neurofibromatosis, type i,lissencephaly 1,pitt-hopkins syndrome,mecp2 duplication syndrome,cdkl5 deficiency disorder,sturge-weber syndrome,alpha-thalassemia/mental retardation syndrome, x-linked,jou bert syndrome 1,coffin-lowry syndrome,williams-beuren syndrome,smith-magenis syndrome,prader-willi syndrome,wolf-hirschhorn syndrome,spinocerebellar ataxia 1,spinocerebellar ataxia 2",0,0,"ataxia-epilepsy syndrome due to slc1a2 deficiency,developmental and epileptic encephalopathy 89; dee89,episodic ataxia, type 2; ea2,spastic paraplegia 47, autosomal recessive; spg47,developmental and epileptic encephalopathy 5; dee5,ataxia, childhood-onset, with central hypomyelination; atcay,spinocerebellar ataxia 13; sca13,developmental and epileptic encephalopathy 31; dee31,dystonia 28, childhood-onset; dyt28,neurodevelopmental disorder with hypotonia and cerebellar atrophy; nedhca","ataxia-epilepsy syndrome due to slc1a2 deficiency,epileptic encephalopathy, early infantile, 4; eiee4,spinocerebellar ataxia, autosomal recessive 16; scar16,spastic paraplegia 47, autosomal recessive; spg47,developmental and epileptic encephalopathy 5; dee5,ataxia, childhood-onset, with central hypomyelination; atcay,cerebellar ataxia, developmental delay, and seizures; caddys,episodic ataxia, type 2; ea2,spastic paraplegia 11, autosomal recessive; spg11,developmental and epileptic encephalopathy 6; dee6,ataxia-telangiectasia; at,dystonia 16; dyt16,spinocerebellar ataxia 13; sca13,epileptic encephalopathy, early infantile, 13; eiee13,neurodegeneration with brain iron accumulation 1; nbia1,pontocerebellar hypoplasia, type 1a; pch1a,spastic paraplegia 15, autosomal recessive; spg15,developmental and epileptic encephalopathy 31; dee31,ataxia with vitamin e deficiency; aved,dystonia-ataxia, childhood-onset; datx",1,1
Neurodevelopmental regression; Lactic acidosis; Failure to thrive; Microcephaly; Hypertrichosis; Myopathy; Muscle weakness; Hypotonia; Peripheral neuropathy,Leigh syndrome,"mitochondrial dna depletion syndrome 1 (mngie type); mtdps1,leigh syndrome; ls,mitochondrial complex i deficiency, nuclear type 1; mc1dn1,pyruvate dehydrogenase e1-alpha deficiency; pdhad,mitochondrial complex iv deficiency; mt-c4d,mitochondrial complex iii deficiency, nuclear type 1; mc3dn1,mitochondrial complex ii deficiency; mt-c2d,mitochondrial dna depletion syndrome 2 (myopathic form); mtdps2,mitochondrial dna depletion syndrome 3 (hepatic form); mtdps3,mitochondrial dna depletion syndrome 4a (alpers type); mtdps4a","leigh syndrome,mitochondrial dna depletion syndrome 1 (mngie type),mitochondrial complex i deficiency,mitochondrial complex iv deficiency,mitochondrial complex iii deficiency,mitochondrial complex v deficiency,pyruvate dehydrogenase e1-alpha deficiency,mitochondrial neurogastrointestinal encephalomyopathy,mitochondrial trifunctional protein deficiency,mitochondrial dna depletion syndrome 2 (myopathic form),mitochondrial dna depletion syndrome 3 (hepatic form),mitochondrial dna depletion syndrome 4a (alpers type),mitochondrial dna depletion syndrome 4b (mngie type),mitochondrial dna depletion syndrome 5 (encephalomyopathic form),mitochondrial dna depletion syndrome 6 (hepatic myopathic form),mitochondrial dna depletion syndrome 7 (hepatic form),mitochondrial dna depletion syndrome 8 (encephalomyopathic form),mitochondrial dna depletion syndrome 9 (hepatic form),mitochondrial dna depletion syndrome 10 (myopathic form),mitochondrial dna depletion syndrome 11 (encephalomyopathic form)",1,1,"leigh syndrome,mitochondrial dna depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria); mtdps5,pyruvate dehydrogenase e1-alpha deficiency,mitochondrial complex i deficiency, nuclear type 1; mc1dn1,combined oxidative phosphorylation deficiency 1; coxpd1,pontocerebellar hypoplasia, type 6; pch6,mitochondrial dna depletion syndrome 13 (encephalomyopathic type); mtdps13,pyruvate carboxylase deficiency,mitochondrial complex iii deficiency, nuclear type 1; mc3dn1,alpers-huttenlocher syndrome; ahs","leigh syndrome,mitochondrial dna depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria),combined oxidative phosphorylation deficiency 1; coxpd1,pyruvate dehydrogenase e1-alpha deficiency,mitochondrial complex i deficiency, nuclear type 1,mitochondrial dna depletion syndrome 13 (encephalomyopathic type),combined oxidative phosphorylation deficiency 2; coxpd2,mitochondrial complex iii deficiency, nuclear type 1,pontocerebellar hypoplasia, type 6; pch6,alpers-huttenlocher syndrome,mitochondrial dna depletion syndrome 7 (hepatocerebral type),combined oxidative phosphorylation deficiency 10; coxpd10,mitochondrial complex iv deficiency,ethylmalonic encephalopathy,mitochondrial dna depletion syndrome 4b (mngie type),spinal muscular atrophy with progressive myoclonic epilepsy,mitochondrial complex v deficiency, nuclear type 2,combined oxidative phosphorylation deficiency 20; coxpd20,mitochondrial dna depletion syndrome 8a (encephalomyopathic type with renal tubulopathy),pyruvate carboxylase deficiency",1,1
Chorea; Dystonia; Akinetic-rigid syndrome; Dysarthria; Facial hypomimia; Saccadic hypometria; Blepharospasm; Dysphagia; Toe walking; Involuntary movements,Neuroferritinopathy,"huntington disease,dyt-tor1a dystonia,parkinson disease 15, autosomal recessive early-onset; park15,dyt-thap1 dystonia,neurodegeneration with brain iron accumulation 1; nbia1,dyt-gnal dystonia,dyt-ano3 dystonia,dyt-kmt2b dystonia,dyt-taf1 dystonia,dyt-atp1a3 dystonia","huntington disease,dyt-tor1a dystonia,parkinson disease 1, autosomal dominant,dyt-thap1 dystonia,dyt-gch1 dystonia,dyt-atp1a3 dystonia,dyt-ano3 dystonia,dyt-kmt2b dystonia,dyt-taf1 dystonia,dyt-prkra dystonia,dyt-hpca dystonia,dyt-ano3 dystonia,dyt-adcy5 dystonia,dyt-thap1 dystonia,dyt-ano3 dystonia,dyt-atp1a3 dystonia,dyt-ano3 dystonia,dyt-ano3 dystonia,dyt-ano3 dystonia,dyt-ano3 dystonia",0,0,"huntington disease; hd,dystonia 1, torsion, autosomal dominant; dyt1,neurodegeneration with brain iron accumulation 1; nbia1,wilson disease; wd,spinocerebellar ataxia 17; sca17,neurodegeneration with brain iron accumulation 2a; nbia2a,dystonia-parkinsonism, rapid-onset; dyt12,chorea-acanthocytosis; chac,huntington disease-like 2; hdl2,mcleod neuroacanthocytosis syndrome; mclds","huntington disease; hd,dystonia 1, torsion, autosomal dominant; dyt1,neurodegeneration with brain iron accumulation 1; nbia1,wilson disease; wd,parkinson disease 1, early-onset; park1,dystonia-parkinsonism, x-linked; xdp,neurodegeneration with brain iron accumulation 2a; nbia2a,chorea, hereditary benign; bhc,dystonia 4, torsion, autosomal dominant; dyt4,neurodegeneration with brain iron accumulation 3; nbia3,dystonia 6, torsion, autosomal dominant; dyt6,chorea-acanthocytosis; chac,mcleod neuroacanthocytosis syndrome; mclds,huntington disease-like 2; hdl2,dystonia 3, torsion, x-linked; dyt3,neurodegeneration with brain iron accumulation 4; nbia4,rapid-onset dystonia-parkinsonism; rdp,ataxia-telangiectasia; at,dystonia 5, torsion; dyt5,pantothenate kinase-associated neurodegeneration; pkan",0,0
Seizures; Progressive weakness; Visual impairment; Adrenal insufficiency; Hypotension; Developmental delay; Optic atrophy; Choreoathetosis; Speech difficulties,ADRENOLEUKODYSTROPHY; ALD,"adrenoleukodystrophy,mitochondrial dna depletion syndrome 1 (mngie type),neuronal ceroid lipofuscinosis 2; cln2,leigh syndrome,wolfram syndrome 1; wfs1,spinocerebellar ataxia, autosomal recessive 1; scar1,coenzyme q10 deficiency, primary, 4; coq10d4,gaucher disease, neuronopathic, type 3,tay-sachs disease,niemann-pick disease, type c1","adrenoleukodystrophy,mitochondrial dna depletion syndrome 12a (hepatic); mtdps12a,mitochondrial dna depletion syndrome 12b (myopathic); mtdps12b,mitochondrial dna depletion syndrome 13 (encephalomyopathic); mtdps13,mitochondrial dna depletion syndrome 14 (myopathic); mtdps14,mitochondrial dna depletion syndrome 15 (encephalomyopathic); mtdps15,mitochondrial dna depletion syndrome 16 (hepatic); mtdps16,mitochondrial dna depletion syndrome 17 (encephalomyopathic); mtdps17,mitochondrial dna depletion syndrome 18 (myopathic); mtdps18,mitochondrial dna depletion syndrome 19 (encephalomyopathic); mtdps19,mitochondrial dna depletion syndrome 20 (myopathic); mtdps20,mitochondrial dna depletion syndrome 21 (encephalomyopathic); mtdps21,mitochondrial dna depletion syndrome 22 (myopathic); mtdps22,mitochondrial dna depletion syndrome 23 (encephalomyopathic); mtdps23,mitochondrial dna depletion syndrome 24 (myopathic); mtdps24,mitochondrial dna depletion syndrome 25 (encephalomyopathic); mtdps25,mitochondrial dna depletion syndrome 26 (myopathic); mtdps26,mitochondrial dna depletion syndrome 27 (encephalomyopathic); mtdps27,mitochondrial dna depletion syndrome 28 (myopathic); mtdps28,mitochondrial dna depletion syndrome 29 (encephalomyopathic); mtdps29",1,1,"adrenoleukodystrophy, x-linked; x-ald,mitochondrial dna depletion syndrome 4b (encephalomyopathic with methylmalonic aciduria); mtdps4b,leigh syndrome; ls,neurodegeneration with brain iron accumulation 2a; nbia2a,mitochondrial complex iii deficiency, nuclear type 1; mc3dn1,spastic paraplegia 55, autosomal recessive; spg55,progressive external ophthalmoplegia with mitochondrial dna deletions 1; peoa1,wolfram syndrome 1; wfs1,mitochondrial dna depletion syndrome 13 (encephalomyopathic type); mtdps13,neurodegeneration with brain iron accumulation 1; nbia1","adrenoleukodystrophy, x-linked; ald,mitochondrial dna depletion syndrome 4b (mngie type); mtdps4b,leigh syndrome; ls,neurodegeneration with brain iron accumulation 2a; nbia2a,aicardi-goutieres syndrome 1; ags1,alexander disease; alxdrd,mitochondrial complex iii deficiency, nuclear type 1; mc3dn1,neurodegeneration with brain iron accumulation 1; nbia1,peroxisome biogenesis disorder 1a (zellweger); pbd1a,mitochondrial dna depletion syndrome 13 (encephalomyopathic type); mtdps13,spastic paraplegia 50, autosomal recessive; spg50,niemann-pick disease, type c1; npc1,gaucher disease, type iii; gd3,mitochondrial complex i deficiency, nuclear type 22; mc1dn22,wolfram syndrome 1; wfs1,neurodegeneration with brain iron accumulation 4; nbia4,mitochondrial dna depletion syndrome 7 (hepatocerebral type); mtdps7,spastic paraplegia 79, autosomal recessive; spg79,pontocerebellar hypoplasia, type 6; pch6,megalencephalic leukoencephalopathy with subcortical cysts 1; mlc1",1,1
Muscular hypotonia; Poor suck; Bilateral ptosis; Slurred speech; Chewing difficulty; Generalized muscle weakness; Facial dysmorphism; Exercise-induced fatigability; Dysarthria; Dysphagia,FOUNTAIN SYNDROME,"myasthenia gravis, congenital, 1a, slow-channel; cms1a,myasthenia gravis, congenital, 1b, fast-channel; cms1b,myasthenia gravis, congenital, 2a, acetylcholine receptor deficiency; cms2a,myasthenia gravis, congenital, 2c, acetylcholine receptor deficiency; cms2c,myasthenia gravis, congenital, 3a, rapid-onset; cms3a,myasthenia gravis, congenital, 4a, slow-channel; cms4a,myasthenia gravis, congenital, 5a, acetylcholine receptor deficiency; cms5a,myasthenia gravis, congenital, 6a, acetylcholine receptor deficiency; cms6a,myasthenia gravis, congenital, 7a, acetylcholine receptor deficiency; cms7a,myasthenia gravis, congenital, 8a, acetylcholine receptor deficiency; cms8a","myasthenia gravis, congenital, 1a, slow-channel; cms1a,myasthenia gravis, congenital, 1b, fast-channel; cms1b,myasthenia gravis, congenital, 2a; cms2a,myasthenia gravis, congenital, 2c; cms2c,myasthenia gravis, congenital, 3a; cms3a,myasthenia gravis, congenital, 4a; cms4a,myasthenia gravis, congenital, 5; cms5,myasthenia gravis, congenital, 6; cms6,myasthenia gravis, congenital, 7; cms7,myasthenia gravis, congenital, 8; cms8,myasthenia gravis, congenital, 9; cms9,myasthenia gravis, congenital, 10; cms10,myasthenia gravis, congenital, 11; cms11,myasthenia gravis, congenital, 12; cms12,myasthenia gravis, congenital, 13; cms13,myasthenia gravis, congenital, 14; cms14,myasthenia gravis, congenital, 15; cms15,myasthenia gravis, congenital, 16; cms16,myasthenia gravis, congenital, 17; cms17,myasthenia gravis, congenital, 18; cms18",0,0,"myasthenic syndrome, congenital, 1a; cms1a,myasthenic syndrome, congenital, 2a; cms2a,myasthenic syndrome, congenital, 3a; cms3a,myasthenic syndrome, congenital, 4a; cms4a,myasthenic syndrome, congenital, 8; cms8,myasthenic syndrome, congenital, 10; cms10,myasthenia gravis, familial; mgfa,muscular dystrophy-dystroglycanopathy type a, 1; mddga1,congenital fiber-type disproportion; cftd,spinal muscular atrophy, type 1; sma1","congenital myasthenic syndrome 1a; cms1a,myasthenia gravis, familial; mgfa,myasthenic syndrome, congenital, 8; cms8,myasthenic syndrome, congenital, 2a; cms2a,congenital myasthenic syndrome 6; cms6,myasthenic syndrome, congenital, 3a; cms3a,centronuclear myopathy 1; cnm1,myotubular myopathy 1; mtm1,congenital fiber-type disproportion 1; cftd1,nemaline myopathy 1; nem1,spinal muscular atrophy, type 1; sma1,myopathy, congenital, with fiber-type disproportion; cftd,muscular dystrophy-dystroglycanopathy type a, 1; mddga1,congenital muscular dystrophy 1a; mdc1a,myasthenic syndrome, congenital, 10; cms10,myasthenic syndrome, congenital, 4a; cms4a,myopathy, centronuclear, 5; cnm5,muscular dystrophy, congenital, megaconial type; mdcmc,myasthenic syndrome, congenital, 7; cms7,myopathy, myofibrillar, 1; mfm1",0,0
Myoclonus; Epilepsy; Muscle weakness; Hearing impairment; Ataxia; Dysarthria; Difficulty swallowing; Fatigue; Exercise intolerance; Seizures,Myoclonic Epilepsy with Ragged-Red Fibers (MERRF) Syndrome,"myoclonic epilepsy with ragged-red fibers; merrf,mitochondrial dna-related myopathy, encephalopathy, lactic acidosis, and stroke-like episodes; melas,neuronal ceroid lipofuscinosis 6; cln6,spinocerebellar ataxia 3; sca3,friedreich ataxia; frda,myoclonic epilepsy of lafora; epm2,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7","myoclonic epilepsy of lafora,myoclonic epilepsy, progressive, with ataxia,myoclonic epilepsy, familial, adult-onset,myoclonic epilepsy, familial, infantile-onset,myoclonic epilepsy, familial, juvenile-onset,myoclonic epilepsy, familial, late-onset,myoclonic epilepsy, familial, with ragged-red fibers,myoclonic epilepsy, familial, with sensorineural deafness,myoclonic epilepsy, familial, with spasticity,myoclonic epilepsy, familial, with visual loss,myoclonic epilepsy, familial, with wolff-parkinson-white syndrome,myoclonic epilepsy, familial, with wolff-parkinson-white syndrome and cardiomyopathy,myoclonic epilepsy, familial, with wolff-parkinson-white syndrome and deafness,myoclonic epilepsy, familial, with wolff-parkinson-white syndrome and myopathy,myoclonic epilepsy, familial, with wolff-parkinson-white syndrome and neuropathy,myoclonic epilepsy, familial, with wolff-parkinson-white syndrome and optic atrophy,myoclonic epilepsy, familial, with wolff-parkinson-white syndrome and retinitis pigmentosa,myoclonic epilepsy, familial, with wolff-parkinson-white syndrome and sensorineural deafness,myoclonic epilepsy, familial, with wolff-parkinson-white syndrome and spasticity,myoclonic epilepsy, familial, with wolff-parkinson-white syndrome and visual loss",1,0,"myoclonic epilepsy, familial adult, 1; fame1,progressive myoclonic epilepsy 1a; epm1a,mitochondrial dna depletion syndrome 4b (encephalomyopathic with methylmalonic aciduria); mtdps4b,myoclonic epilepsy and ragged red fibers; merrf,spinocerebellar ataxia 1; sca1,mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes; melas,progressive myoclonic epilepsy 2a; epm2a,ataxia-deafness-dementia syndrome,leigh syndrome; ls,unverricht-lundborg syndrome; uld","progressive myoclonus epilepsy 1a; epm1a,myoclonic epilepsy, familial adult, 1; fame1,mitochondrial dna depletion syndrome 4b; mtdps4b,spinocerebellar ataxia 1; sca1,myoclonus-dystonia syndrome; mds,leigh syndrome; ls,mitochondrial encephalopathy with lactic acidosis and stroke-like episodes; melas,progressive myoclonus epilepsy 2a; epm2a,friedreich ataxia 1; frda1,unverricht-lundborg syndrome; uld,myoclonic epilepsy and ragged red fibers; merrf,ataxia-telangiectasia; at,spinocerebellar ataxia 2; sca2,lafora disease; ld,neurodegeneration with brain iron accumulation 1; nbia1,progressive myoclonus epilepsy 3; epm3,mitochondrial dna depletion syndrome 7; mtdps7,spinocerebellar ataxia 3; sca3,ceroid lipofuscinosis, neuronal, 1; cln1,gaucher disease, type 3; gd3",0,0
Frequent intractable seizures; Visual impairment; Absence of neck holding; Generalized tonic-clonic seizures; Macrocephaly; Setting sun eyes; Tremor; Hypotonia; Optic atrophy,CANAVAN DISEASE,"megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1; mpph1,aicardi syndrome,leigh syndrome, french-canadian type,mitochondrial complex i deficiency,mitochondrial complex iv deficiency,mitochondrial complex v deficiency,mitochondrial dna depletion syndrome 1 (mngie type),mitochondrial dna depletion syndrome 2 (myopathic type),mitochondrial dna depletion syndrome 3 (hepatic type),mitochondrial dna depletion syndrome 4a (alpers type)","megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1; mpph1,aicardi syndrome,aicardi-goutieres syndrome 1; ags1,alpers-huttenlocher syndrome,dravet syndrome,west syndrome,lissencephaly 1; lis1,lissencephaly 2; lis2,lissencephaly 3; lis3,lissencephaly 4; lis4,lissencephaly 5; lis5,lissencephaly 6; lis6,lissencephaly 7; lis7,lissencephaly 8; lis8,lissencephaly 9; lis9,lissencephaly 10; lis10,lissencephaly 11; lis11,lissencephaly 12; lis12,lissencephaly 13; lis13,lissencephaly 14; lis14",0,0,"epileptic encephalopathy, early infantile, 4; eiee4,neurodegeneration with brain iron accumulation 1; nbia1,pontocerebellar hypoplasia, type 6; pch6,mitochondrial dna depletion syndrome 7 (hepatocerebral type); mtdps7,alpers-huttenlocher syndrome; ahs,epileptic encephalopathy, early infantile, 25; eiee25,spastic paraplegia 50, autosomal recessive; spg50,progressive external ophthalmoplegia with mitochondrial dna deletions 1; peoa1,leigh syndrome; ls,neurodegeneration with brain iron accumulation 2a; nbia2a","epileptic encephalopathy, early infantile, 4; eiee4,neurodegeneration with brain iron accumulation 1; nbia1,epileptic encephalopathy, early infantile, 2; eiee2,progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy; peho,mitochondrial dna depletion syndrome 7; mtdps7,pontocerebellar hypoplasia, type 6; pch6,alpers-huttenlocher syndrome; ahs,epileptic encephalopathy, early infantile, 5; eiee5,neurodegeneration with brain iron accumulation 2a; nbia2a,leigh syndrome; ls,epileptic encephalopathy, early infantile, 6; eiee6,mitochondrial complex iii deficiency, nuclear type 1; mc3dn1,neurodegeneration with brain iron accumulation 4; nbia4,pontocerebellar hypoplasia, type 1b; pch1b,epileptic encephalopathy, early infantile, 25; eiee25,mitochondrial dna depletion syndrome 13; mtdps13,spastic paraplegia 50, autosomal recessive; spg50,wolfram syndrome 1; wfs1,pontocerebellar hypoplasia, type 2a; pch2a,mitochondrial complex i deficiency, nuclear type 1; mc1dn1",0,0
Seizures; Gait imbalance; Tremor; Cognitive impairment; Ataxia; Dysdiadochokinesia; Dysmetria,Labrune syndrome,"spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 8; sca8,spinocerebellar ataxia 10; sca10,spinocerebellar ataxia 12; sca12,spinocerebellar ataxia 13; sca13,spinocerebellar ataxia 17; sca17","spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 8; sca8,spinocerebellar ataxia 10; sca10,spinocerebellar ataxia 12; sca12,spinocerebellar ataxia 13; sca13,spinocerebellar ataxia 17; sca17,friedreich ataxia; frda,ataxia-telangiectasia; a-t,dentatorubral-pallidoluysian atrophy; drpla,glut1 deficiency syndrome 1; glut1ds1,unvericht-lundborg syndrome; epm1,juvenile myoclonic epilepsy; jme,angelman syndrome; as,lafora disease; ld,neuronal ceroid lipofuscinosis 2; cln2,neuronal ceroid lipofuscinosis 6; cln6",0,0,"spinocerebellar ataxia 13; sca13,episodic ataxia, type 2; ea2,ataxia-telangiectasia; at,progressive myoclonic epilepsy 1a; epm1a,spinocerebellar ataxia 6; sca6,neurodegeneration with brain iron accumulation 1; nbia1,unverricht-lundborg syndrome; uld,lafora disease; epm2,spinocerebellar ataxia 2; sca2,dentatorubral-pallidoluysian atrophy; drpla","spinocerebellar ataxia 1; sca1,episodic ataxia, type 2; ea2,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,ataxia-telangiectasia; at,progressive myoclonic epilepsy 1a; epm1a,unverricht-lundborg syndrome; uld,lafora disease; ld,neurodegeneration with brain iron accumulation 1; nbia1,dentatorubral-pallidoluysian atrophy; drpla,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,friedreich ataxia 1; frda1,myoclonus-dystonia syndrome; mds,progressive myoclonic epilepsy 2a; epm2a,spinocerebellar ataxia 13; sca13,ataxia with vitamin e deficiency; aved,cerebrotendinous xanthomatosis; ctx,niemann-pick disease, type c1; npc1,gaucher disease, type 3; gd3",0,0
Overgrowth; Frequent laughter; Ataxia; Limb hypertonia; No intelligible speech; Deep-set eyes; Protruding tongue; Prominent chin; Febrile seizures,ANGELMAN SYNDROME; AS,"angelman syndrome,sotos syndrome 1,weaver syndrome,beckwith-wiedemann syndrome,simpson-golabi-behmel syndrome, type 1,kabuki syndrome 1,marshall-smith syndrome,malan syndrome,perlisch syndrome,bannayan-riley-ruvalcaba syndrome","angelman syndrome,sotos syndrome 1,weaver syndrome,beckwith-wiedemann syndrome,simpson-golabi-behmel syndrome, type 1,kabuki syndrome 1,marshall-smith syndrome,malan syndrome,perlisch syndrome,bannayan-riley-ruvalcaba syndrome,macrocephaly/autism syndrome,cowden syndrome 1,pten hamartoma tumor syndrome,pallister-killian syndrome,rubinstein-taybi syndrome 1,smith-magenis syndrome,mowat-wilson syndrome,cohen syndrome,borjeson-forssman-lehmann syndrome,bardet-biedl syndrome 1",1,1,"angelman syndrome; as,epileptic encephalopathy, early infantile, 1; eiee1,joubert syndrome 1; jbts1,sotos syndrome 1; sotos1,christianson syndrome,pitt-hopkins syndrome; pths,epileptic encephalopathy, early infantile, 4; eiee4,mental retardation, autosomal dominant 1; mrd1,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1; camrq1,ataxia-telangiectasia; at","angelman syndrome; as,sotos syndrome 1; sotos1,weaver syndrome; wvs,simpson-golabi-behmel syndrome, type 1; sgbs1,bannayan-riley-ruvalcaba syndrome; brrs,cerebral gigantism-epilepsy-facial dysmorphism syndrome,epilepsy, nocturnal frontal lobe, 1; enfl1,joubert syndrome 1; jbts1,ataxia-telangiectasia; at,christianson syndrome; csnk,pitt-hopkins syndrome; pths,rett syndrome; rtt,mowat-wilson syndrome; mows,schaaf-yang syndrome; shfyng,kleefstra syndrome 1; ks1,epileptic encephalopathy, early infantile, 4; eiee4,pallister-killian syndrome; pks,cohen syndrome; coh1,macrocephaly-capillary malformation syndrome; mcap,epileptic encephalopathy, early infantile, 2; eiee2",1,1
Distal lower extremity weakness; Proximal lower extremity weakness; Upper arm weakness; Waddling gait; Foot drop; Intermittent nasal bleeding; Ecchymosis; Purpura; Absent ankle reflexes,GNE myopathy,"charcot-marie-tooth disease, axonal, type 2a1; cmt2a1,charcot-marie-tooth disease, type 1a; cmt1a,charcot-marie-tooth disease, type 1b; cmt1b,charcot-marie-tooth disease, type 1c; cmt1c,charcot-marie-tooth disease, type 1d; cmt1d,charcot-marie-tooth disease, type 1e; cmt1e,charcot-marie-tooth disease, type 2b1; cmt2b1,charcot-marie-tooth disease, type 2b2; cmt2b2,charcot-marie-tooth disease, type 2c; cmt2c,charcot-marie-tooth disease, type 2d; cmt2d","charcot-marie-tooth disease, type 1a,charcot-marie-tooth disease, type 1b,charcot-marie-tooth disease, type 2a1,charcot-marie-tooth disease, type 2b,charcot-marie-tooth disease, type 2c,charcot-marie-tooth disease, type 2d,charcot-marie-tooth disease, type 2e,charcot-marie-tooth disease, type 2f,charcot-marie-tooth disease, type 2g,charcot-marie-tooth disease, type 2i,charcot-marie-tooth disease, type 2j,charcot-marie-tooth disease, type 2k,charcot-marie-tooth disease, type 2l,charcot-marie-tooth disease, type 2m,charcot-marie-tooth disease, type 2n,charcot-marie-tooth disease, type 2o,charcot-marie-tooth disease, type 2p,charcot-marie-tooth disease, type 2q,charcot-marie-tooth disease, type 2r,charcot-marie-tooth disease, type 2s",0,0,"charcot-marie-tooth disease, type 2a1; cmt2a1,muscular dystrophy-dystroglycanopathy type a9; mddga9,limb-girdle muscular dystrophy, type 2b; lgmd2b,miyoshi muscular dystrophy 1; mmd1,hereditary motor and sensory neuropathy, type iic; hmsn2c,spinal muscular atrophy, distal, autosomal recessive, 1; dsma1,muscular dystrophy, limb-girdle, type 2l; lgmd2l,neuropathy, hereditary motor and sensory, type iid; hmsn2d,muscular dystrophy, congenital, fukuyama type; fcmd,distal spinal muscular atrophy, type 2; dsma2","charcot-marie-tooth disease, type 2a1; cmt2a1,muscular dystrophy-dystroglycanopathy type a1; mddga1,spinal muscular atrophy, distal, autosomal recessive, 2; dsma2,muscular dystrophy, limb-girdle, type 2b; lgmd2b,miyoshi muscular dystrophy 1; mmd1,hereditary motor and sensory neuropathy, type iic; hmsn2c,muscular dystrophy, congenital, fukuyama type; fcmd,neuropathy, hereditary motor and sensory, type iia; hmsn2a,spinal muscular atrophy, late-onset, finkel type; smafk,muscular dystrophy, limb-girdle, type 2i; lgmd2i,neuropathy, hereditary motor, type iib; hmn2b,muscular dystrophy, limb-girdle, type 2l; lgmd2l,neuropathy, hereditary motor and sensory, type iid; hmsn2d,muscular dystrophy, limb-girdle, type 2a; lgmd2a,spinal muscular atrophy, distal, autosomal dominant, 1; dsma1,neuropathy, hereditary sensory and autonomic, type ii; hsan2,muscular dystrophy, limb-girdle, type 2d; lgmd2d,neurop",0,0
Gait disorder; Proximal muscle weakness; Amyotrophy; Elevated serum creatine kinase; Achilles tendon contractures; Scapular winging; Axial muscle weakness; Low vital capacity; Myotonic discharges,X-linked Myopathy with Excessive Autophagy,"bethlem myopathy 1,emery-dreifuss muscular dystrophy 1, x-linked,limb-girdle muscular dystrophy, autosomal dominant 1,facioscapulohumeral muscular dystrophy 1,myotonic dystrophy 1,ullrich congenital muscular dystrophy 1,charcot-marie-tooth disease, axonal, type 2a1,congenital fiber-type disproportion myopathy,central core disease of muscle,nemaline myopathy 1","bethlem myopathy 1,ullrich congenital muscular dystrophy 1,limb-girdle muscular dystrophy, type 2a,limb-girdle muscular dystrophy, type 2b,limb-girdle muscular dystrophy, type 2i,limb-girdle muscular dystrophy, type 1c,emery-dreifuss muscular dystrophy 1, x-linked,emery-dreifuss muscular dystrophy 2, autosomal dominant,emery-dreifuss muscular dystrophy 3, autosomal recessive,facioscapulohumeral muscular dystrophy 1,facioscapulohumeral muscular dystrophy 2,myotonic dystrophy 1,myotonic dystrophy 2,charcot-marie-tooth disease, axonal, type 2a2,charcot-marie-tooth disease, axonal, type 2b,charcot-marie-tooth disease, axonal, type 2c,charcot-marie-tooth disease, axonal, type 2d,charcot-marie-tooth disease, axonal, type 2e,charcot-marie-tooth disease, axonal, type 2f,charcot-marie-tooth disease, axonal, type 2g",0,0,"muscular dystrophy, limb-girdle, type 2a; lgmd2a,myotonic dystrophy 1; dm1,muscular dystrophy, limb-girdle, type 2b; lgmd2b,emery-dreifuss muscular dystrophy 1; edmd1,muscular dystrophy, facioscapulohumeral, 1; fshd1,myopathy, myofibrillar, 1; mfm1,muscular dystrophy, congenital, rigid spine, 1; rsmd1,muscular dystrophy, limb-girdle, type 2l; lgmd2l,myopathy, centronuclear, 1; cnm1,nemaline myopathy 1; nem1","muscular dystrophy, limb-girdle, type 2a; lgmd2a,myotonic dystrophy 1; dm1,muscular dystrophy, limb-girdle, type 2b; lgmd2b,emery-dreifuss muscular dystrophy 1; edmd1,muscular dystrophy, facioscapulohumeral, 1; fshd1,myopathy, myofibrillar, 1; mfm1,muscular dystrophy, congenital, rigid spine, 1; rsmd1,nemaline myopathy 1; nem1,myopathy, centronuclear, 1; cnm1,muscular dystrophy, limb-girdle, type 2i; lgmd2i,bethlem myopathy 1; bthlm1,myopathy, distal, 1; mpd1,muscular dystrophy, congenital, 1a; mdc1a,myopathy, myofibrillar, desmin-related; mfm-des,scapuloperoneal syndrome, neurogenic, x-linked; spsn,muscular dystrophy, limb-girdle, type 2l; lgmd2l,myopathy with early respiratory failure; merf,myopathy, distal, with anterior tibial onset; mpdt,muscular dystrophy, limb-girdle, type 2d; lgmd2d,myopathy, reducing body, x-linked; rbmx",0,0
Cerebellar ataxia; Dysarthria; Dystonic tremor; Areflexia; Dysmetria; Ataxic gait; Pes cavus,Ataxia with vitamin E deficiency,"friedreich ataxia,spinocerebellar ataxia 3; sca3,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 17; sca17,spinocerebellar ataxia 8; sca8,spinocerebellar ataxia 10; sca10,spinocerebellar ataxia 12; sca12","friedreich ataxia,spinocerebellar ataxia 3; sca3,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 17; sca17,spinocerebellar ataxia 8; sca8,spinocerebellar ataxia 10; sca10,spinocerebellar ataxia 12; sca12,spinocerebellar ataxia 13; sca13,spinocerebellar ataxia 14; sca14,spinocerebellar ataxia 15; sca15,spinocerebellar ataxia 16; sca16,spinocerebellar ataxia 19; sca19,spinocerebellar ataxia 20; sca20,spinocerebellar ataxia 21; sca21,spinocerebellar ataxia 23; sca23,spinocerebellar ataxia 27; sca27,spinocerebellar ataxia 28; sca28",0,0,"friedreich ataxia 1; frda,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,ataxia with vitamin e deficiency; aved,cerebellar ataxia, neuropathy, and vestibular areflexia syndrome; canvas,spinocerebellar ataxia 8; sca8,ataxia-telangiectasia; at,early-onset cerebellar ataxia with retained tendon reflexes; eoca,marinesco-sjogren syndrome; mss","friedreich ataxia 1; frda,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,ataxia with vitamin e deficiency; aved,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,ataxia-telangiectasia; at,cerebellar ataxia, deafness, and narcolepsy, autosomal dominant; adcadn,spinocerebellar ataxia 8; sca8,spinocerebellar ataxia 10; sca10,spinocerebellar ataxia 13; sca13,ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia; eaoh,machado-joseph disease; mjd,cerebellar ataxia and hypogonadotropic hypogonadism; cahh,spinocerebellar ataxia 28; sca28,ataxia, posterior column, with retinitis pigmentosa; axpc1,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1; camrq1,spastic ataxia 1, autosomal dominant; spax1,episodic ataxia, type 2; ea2",1,1
Muscular weakness; Elevated creatine kinase; Muscular hypotonia; Vomiting; Dysarthria; Clumsy gait; Lumbar hyperlordosis; Winged scapula; Reduced tendon reflexes,MYOPATHY WITH EXTRAPYRAMIDAL SIGNS; MPXPS,"muscular dystrophy, duchenne type; dmd,muscular dystrophy, becker type; bmd,limb-girdle muscular dystrophy, type 2a; lgmdr1,limb-girdle muscular dystrophy, type 2b; lgmdr2,charcot-marie-tooth disease, type 2a1; cmt2a1,charcot-marie-tooth disease, type 2b; cmt2b,charcot-marie-tooth disease, type 2c; cmt2c,charcot-marie-tooth disease, type 2d; cmt2d,charcot-marie-tooth disease, type 2e; cmt2e,charcot-marie-tooth disease, type 2f; cmt2f","muscular dystrophy, duchenne type,muscular dystrophy, becker type,bethlem myopathy 1,limb-girdle muscular dystrophy, type 2a,limb-girdle muscular dystrophy, type 2b,limb-girdle muscular dystrophy, type 2c,limb-girdle muscular dystrophy, type 2d,limb-girdle muscular dystrophy, type 2e,limb-girdle muscular dystrophy, type 2f,limb-girdle muscular dystrophy, type 2g,limb-girdle muscular dystrophy, type 2h,limb-girdle muscular dystrophy, type 2i,limb-girdle muscular dystrophy, type 2j,limb-girdle muscular dystrophy, type 2k,limb-girdle muscular dystrophy, type 2l,limb-girdle muscular dystrophy, type 2m,limb-girdle muscular dystrophy, type 2n,limb-girdle muscular dystrophy, type 2o,limb-girdle muscular dystrophy, type 2p,limb-girdle muscular dystrophy, type 2q",0,0,"muscular dystrophy, limb-girdle, autosomal recessive 2a; lgmdr2,muscular dystrophy, duchenne type; dmd,muscular dystrophy, becker type; bmd,spinal muscular atrophy, type ii; sma2,congenital muscular dystrophy 1a; mdc1a,myasthenia gravis, familial; fmg,muscular dystrophy, congenital, fukuyama type; fcmd,pompe disease, late-onset; lopd,muscular dystrophy, limb-girdle, autosomal recessive 2i; lgmdr9,spinal muscular atrophy, type iii; sma3","muscular dystrophy, limb-girdle, autosomal recessive 2a; lgmdr2,muscular dystrophy, duchenne type; dmd,muscular dystrophy, becker type; bmd,spinal muscular atrophy, type ii; sma2,congenital muscular dystrophy 1a; mdc1a,myasthenia gravis, familial; mgfa,congenital myasthenic syndrome 1a; cms1a,muscular dystrophy, congenital, fukuyama type; fcmd,pompe disease, glycogen storage disease ii; gsd2,muscular dystrophy, limb-girdle, autosomal recessive 2i; lgmdr9,spinal muscular atrophy, type iii; sma3,muscular dystrophy-dystroglycanopathy type a1; mddga1,myopathy, centronuclear, x-linked; cnmx,muscular dystrophy, limb-girdle, autosomal recessive 2b; lgmdr2,congenital fiber-type disproportion; cftd,myopathy, congenital, with fiber-type disproportion; cftdm,nemaline myopathy 1; nem1,muscular dystrophy, emery-dreifuss 1, x-linked; edmd1,myopathy, myofibrillar, 1; mfm1,muscular dystrophy, limb-girdle, autosomal dominant 1b; lgmdd",0,0
dystonia; bradykinesia; tremor; micrographia; freezing; festination; retropulsion; autonomic dysfunction; psychosis; hyperreflexia,Parkinson disease 4,"parkinson disease 1, autosomal dominant; park1,parkinson disease 2, autosomal recessive; park2,parkinson disease 3, autosomal dominant; park3,parkinson disease 4, autosomal dominant; park4,parkinson disease 5, autosomal recessive; park5,parkinson disease 6, autosomal recessive, early-onset; park6,parkinson disease 7, autosomal recessive, early-onset; park7,parkinson disease 8, autosomal dominant; park8,parkinson disease 9, autosomal dominant; park9,parkinson disease 10, autosomal dominant; park10","parkinson disease 1; park1,parkinson disease 2, autosomal recessive; park2,parkinson disease 3; park3,parkinson disease 4, autosomal dominant; park4,parkinson disease 5, autosomal recessive; park5,parkinson disease 6, autosomal recessive, early-onset; park6,parkinson disease 7, autosomal recessive, early-onset; park7,parkinson disease 8; park8,parkinson disease 9; park9,parkinson disease 10; park10,parkinson disease 11; park11,parkinson disease 12, autosomal dominant; park12,parkinson disease 13, autosomal dominant; park13,parkinson disease 14, autosomal recessive; park14,parkinson disease 15, autosomal recessive; park15,parkinson disease 16, autosomal recessive; park16,parkinson disease 17, autosomal dominant; park17,parkinson disease 18, autosomal recessive; park18,parkinson disease 19, autosomal dominant; park19,parkinson disease 20, autosomal recessive; park20",1,1,"parkinson disease 1, autosomal dominant; park1,dystonia-parkinsonism, early-onset; dyt-park,neurodegeneration with brain iron accumulation 1; nbia1,dyt-tor1a dystonia; dyt-tor1a,parkinson disease 2, autosomal recessive juvenile; park2,rapid-onset dystonia-parkinsonism; rdp,kufor-rakeb syndrome; krs,neurodegeneration with brain iron accumulation 3; nbia3,dystonia 24; dyt24,parkinson disease 6, autosomal recessive early-onset; park6","parkinson disease 1, autosomal dominant; park1,dopa-responsive dystonia; drd,dystonia 1, torsion, autosomal dominant; dyt1,neurodegeneration with brain iron accumulation 1; nbia1,rapid-onset dystonia-parkinsonism; rdp,parkinson disease 2, autosomal recessive juvenile; park2,dystonia-parkinsonism, x-linked; xdp,multiple system atrophy 1; msa1,parkinson disease 6, autosomal recessive early-onset; park6,dystonia 4, torsion, autosomal dominant; dyt4,neurodegeneration with brain iron accumulation 2a; nbia2a,parkinson disease 7, autosomal recessive early-onset; park7,dystonia 16; dyt16,kufor-rakeb syndrome; krs,neurodegeneration with brain iron accumulation 3; nbia3,dystonia-parkinsonism, adult-onset; dyt3,parkinson disease 15, autosomal recessive; park15,dystonia 12; dyt12,perry syndrome,neurodegeneration with brain iron accumulation 4; nbia4",0,0
Progressive left limb weakness; Cognitive impairment; Memory decline; Decreased calculation ability; Frontal gait disorder; Involuntary tremor; Fecal incontinence; Urinary incontinence,Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia,"amyotrophic lateral sclerosis 1; als1,frontotemporal dementia and/or amyotrophic lateral sclerosis 1; ftdals1,parkinson disease 1; park1,alzheimer disease, familial, 1; ad1,huntington disease; hd,multiple system atrophy 1; msa1,progressive supranuclear palsy 1; psp1,corticobasal degeneration; cbd,spinocerebellar ataxia 3; sca3,dementia, frontotemporal, with parkinsonism; dftdp","amyotrophic lateral sclerosis 1; als1,frontotemporal dementia and/or amyotrophic lateral sclerosis 1; ftdals1,frontotemporal dementia with parkinsonism-17; ftdp17,alzheimer disease 1; ad1,parkinson disease 1, autosomal dominant; park1,huntington disease; hd,spinocerebellar ataxia 3; sca3,progressive supranuclear palsy 1; psp1,multiple system atrophy 1; msa1,corticobasal degeneration; cbd,dementia, lewy body; dlb,spinal muscular atrophy, adult-onset; sma,charcot-marie-tooth disease, axonal, type 2a1; cmt2a1,neurodegeneration with brain iron accumulation 1; nbia1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 17; sca17,spinocerebellar ataxia 8; sca8",0,0,"frontotemporal dementia; ftd,alzheimer disease, early-onset; eoad,neurodegeneration with brain iron accumulation 1; nbia1,adult-onset leukoencephalopathy with axonal spheroids and pigmented glia; alsp,cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; cadasil,progressive supranuclear palsy 1; psp1,corticobasal degeneration; cbd,normal pressure hydrocephalus; nph,multiple system atrophy 1; msa1,hereditary diffuse leukoencephalopathy with spheroids; hdls","frontotemporal dementia; ftd,alzheimer disease; ad,neurodegeneration with brain iron accumulation 1; nbia1,adult-onset leukoencephalopathy with axonal spheroids and pigmented glia; alsp,cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; cadasil,progressive supranuclear palsy 1; ppsp1,corticobasal degeneration; cbd,multiple system atrophy; msa,hereditary diffuse leukoencephalopathy with spheroids; hdls,adult polyglucosan body disease; apbd,neurodegeneration with brain iron accumulation 4; nbia4,spastic paraplegia 11; spg11,alexander disease; alxdrd,adult-onset autosomal dominant leukodystrophy; adld,cerebral amyloid angiopathy, app-related; caa-app,huntington disease-like 1; hdl1,neurodegeneration with brain iron accumination 2a; nbia2a,kufor-rakeb syndrome; krs,neurodegeneration with brain iron accumulation 2b; nbia2b,adult-onset neurodegeneration with brain iron accumulation; anbia",1,1
Migraine; Cognitive impairment; Visual disturbance; Slurred speech; Dysphasia; Numbness; Confusion; Nocturia; Restlessness; Agitation,"CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1; CADASIL1","cadasil,melas syndrome,familial hemiplegic migraine,rett syndrome,spinocerebellar ataxia type 6,mitochondrial dna-related diseases,neurofibromatosis type 1,leigh syndrome,alzheimer disease, familial, 1,frontotemporal dementia with parkinsonism-17; ftdp-17","cadasil,melas syndrome,familial hemiplegic migraine,rett syndrome,spinocerebellar ataxia type 6,mitochondrial dna-related diseases,neurofibromatosis type 1,leigh syndrome,alzheimer disease, familial, 1,huntington disease,charcot-marie-tooth disease, type 2a1,frontotemporal dementia and/or amyotrophic lateral sclerosis 1; ftdals1,spinocerebellar ataxia type 2,spinocerebellar ataxia type 3,spinocerebellar ataxia type 7,spinocerebellar ataxia type 17,neurodegeneration with brain iron accumulation 1; nbia1,wilson disease,parkinson disease 1, autosomal dominant,fragile x syndrome",0,0,"cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1; cadasil1,migraine, familial hemiplegic, 1; fhm1,mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes; melas,cerebral amyloid angiopathy, app-related; caa-app,migraine, familial hemiplegic, 2; fhm2,cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 2; cadasil2,spinocerebellar ataxia 6; sca6,migraine with or without aura, susceptibility to, 1; mgr1,cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy; carasil,alexander disease; alxdrd","cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1; cadasil1,migraine, familial hemiplegic, 1; fhm1,migraine, familial hemiplegic, 2; fhm2,cerebral amyloid angiopathy, app-related; caa-app,mitochondrial encephalopathy with lactic acidosis and stroke-like episodes; melas,cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 2; cadasil2,migraine, sporadic hemiplegic; shm,cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy; carasil,hereditary vascular retinopathy; hvr,cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy 3; cadasil3,migraine with or without aura, susceptibility to, 1; mgr1,alexander disease; alxdrd,adult-onset leukoencephalopathy with axonal spheroids and pigmented glia; alsp,cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy 2; carasil2,cerebral amyloid angiopathy, cst3-related; caa-cst3,mitochondrial dna depletion syndrome 13; mtdps13,leukoencephalopathy with vanishing white matter; vwm",1,1
Proximal muscle weakness; Distal muscle weakness; Scapuloperoneal muscle weakness; Loss of ambulation; Respiratory insufficiency; Arthrogryposis; Scoliosis; Pes cavus; Vocal cord paralysis; Gynecomastia,Spinal muscular atrophy,"charcot-marie-tooth disease, axonal, type 2a1; cmt2a1,charcot-marie-tooth disease, axonal, type 2a2a; cmt2a2a,charcot-marie-tooth disease, axonal, type 2b1; cmt2b1,charcot-marie-tooth disease, axonal, type 2b2; cmt2b2,charcot-marie-tooth disease, axonal, type 2c; cmt2c,charcot-marie-tooth disease, axonal, type 2d; cmt2d,charcot-marie-tooth disease, axonal, type 2e; cmt2e,charcot-marie-tooth disease, axonal, type 2f; cmt2f,charcot-marie-tooth disease, axonal, type 2g; cmt2g,charcot-marie-tooth disease, axonal, type 2h; cmt2h","charcot-marie-tooth disease, axonal, type 2a1; cmt2a1,charcot-marie-tooth disease, axonal, type 2a2a; cmt2a2a,charcot-marie-tooth disease, axonal, type 2b1; cmt2b1,charcot-marie-tooth disease, axonal, type 2b2; cmt2b2,charcot-marie-tooth disease, axonal, type 2c; cmt2c,charcot-marie-tooth disease, axonal, type 2d; cmt2d,charcot-marie-tooth disease, axonal, type 2e; cmt2e,charcot-marie-tooth disease, axonal, type 2f; cmt2f,charcot-marie-tooth disease, axonal, type 2g; cmt2g,charcot-marie-tooth disease, axonal, type 2i; cmt2i,charcot-marie-tooth disease, axonal, type 2j; cmt2j,charcot-marie-tooth disease, axonal, type 2k; cmt2k,charcot-marie-tooth disease, axonal, type 2l; cmt2l,charcot-marie-tooth disease, axonal, type 2m; cmt2m,charcot-marie-tooth disease, axonal, type 2n; cmt2n,charcot-marie-tooth disease, axonal, type 2o; cmt2o,charcot-marie-tooth disease, axonal, type 2p; cmt2p,charcot-marie-tooth disease, axonal, type 2q; cmt2q,charcot-marie-tooth disease, axonal, type 2r; cmt2r,charcot-marie-tooth disease, axonal, type 2s; cmt2s",0,0,"scapuloperoneal spinal muscular atrophy; spsma,emery-dreifuss muscular dystrophy 1, x-linked; edmd1,muscular dystrophy, limb-girdle, type 2l; lgmd2l,spinal muscular atrophy, type 1; sma1,centronuclear myopathy 1; cnm1,nemaline myopathy 2; nem2,congenital myopathy with fiber-type disproportion; cftd,muscular dystrophy, congenital, 1a; mdc1a,myopathy, centronuclear, x-linked; cnmx,scapuloperoneal syndrome, neurogenic type","scapuloperoneal spinal muscular atrophy; spsma,muscular dystrophy, emery-dreifuss, 1, x-linked; edmd1,muscular dystrophy, emery-dreifuss, 2, autosomal dominant; edmd2,muscular dystrophy, limb-girdle, type 1b; lgmd1b,spinal muscular atrophy, distal, autosomal recessive, 1; dsma1,muscular dystrophy, congenital, 1a; mdc1a,myopathy, centronuclear, x-linked; cnmx,nemaline myopathy 1; nem1,myopathy, myofibrillar, 1; mfm1,spinal muscular atrophy, lower extremity-predominant, 1; sma-led1,muscular dystrophy, facioscapulohumeral, 1; fshd1,myopathy, congenital, with fiber-type disproportion; cftd,arthrogryposis multiplex congenita, neurogenic type; amcn,spinal muscular atrophy with respiratory distress 1; smard1,muscular dystrophy, congenital, merosin-deficient, 1a; mdc1a,myopathy, distal, with anterior tibial onset; mpd1,scapuloperoneal syndrome, neurogenic, autosomal dominant,muscular dystrophy, bethlem type 1; bthlm1,myopathy, reducing",1,1
Gait ataxia; Tremor; Wide-based gait; Loss of position sense; Positive Romberg sign; Pes cavus; Scoliosis; Decreased proprioception; Foot drop; Steppage gait,Friedreich ataxia,"friedreich ataxia,charcot-marie-tooth disease, type 1a,charcot-marie-tooth disease, type 1b,charcot-marie-tooth disease, type 2a1,charcot-marie-tooth disease, type 2e,charcot-marie-tooth disease, type 4a,charcot-marie-tooth disease, type 4b1,charcot-marie-tooth disease, type 4c,charcot-marie-tooth disease, type 4d,charcot-marie-tooth disease, type 4e","friedreich ataxia,charcot-marie-tooth disease, type 1a,charcot-marie-tooth disease, type 1b,charcot-marie-tooth disease, type 2a1,charcot-marie-tooth disease, type 2e,charcot-marie-tooth disease, type 4a,charcot-marie-tooth disease, type 4b1,charcot-marie-tooth disease, type 4c,charcot-marie-tooth disease, type 4d,charcot-marie-tooth disease, type 4e,charcot-marie-tooth disease, type 4f,charcot-marie-tooth disease, type 4g,charcot-marie-tooth disease, type 4h,charcot-marie-tooth disease, type 4j,charcot-marie-tooth disease, type 4k,charcot-marie-tooth disease, type 4l,charcot-marie-tooth disease, type 4m,charcot-marie-tooth disease, type 4n,charcot-marie-tooth disease, type 4o,charcot-marie-tooth disease, type 4p",1,1,"friedreich ataxia 1; frda,charcot-marie-tooth disease, type 1a; cmt1a,hereditary sensory and autonomic neuropathy type i; hsan1,spinocerebellar ataxia 1; sca1,dejerine-sottas disease; dss,hereditary motor and sensory neuropathy type iib; hmsn2b,spinocerebellar ataxia 2; sca2,charcot-marie-tooth disease, type 1b; cmt1b,hereditary sensory neuropathy, type ia; hsn1a,roussy-levy syndrome; rls","friedreich ataxia 1; frda,charcot-marie-tooth disease, type 1a; cmt1a,hereditary sensory and autonomic neuropathy type i; hsan1,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,dejerine-sottas disease; dss,hereditary motor and sensory neuropathy type iib; hmsn2b,spinocerebellar ataxia 6; sca6,ataxia with vitamin e deficiency; aved,hereditary sensory neuropathy type ia; hsn1a,spinocerebellar ataxia 7; sca7,charcot-marie-tooth disease, type 1b; cmt1b,hereditary motor and sensory neuropathy type iia; hmsn2a,spinocerebellar ataxia 8; sca8,cerebellar ataxia, neuropathy, and vestibular areflexia syndrome; canvas,charcot-marie-tooth disease, type 2a1; cmt2a1,spinocerebellar ataxia 10; sca10,hereditary sensory and autonomic neuropathy type ii; hsan2,ataxia-telangiectasia; at",1,1
Arthrogryposis multiplex congenita; Thoracic hypoplasia; Thoracic scoliosis; Hyperekplexia; Hypotonia; Apnea; Bradycardia; Epileptic spasms; Delayed myelination of the corpus callosum; Enlarged lateral ventricles,Neonatal developmental and epileptic encephalopathy with movement disorders and arthrogryposis,"arthrogryposis, distal, type 1a; da1a,hypoplasia of the thoracic cage and lung; htcl,hyperekplexia 1; hkpx1,congenital myopathy with fiber-type disproportion; cmftd,central hypoventilation syndrome, congenital; cchs,epileptic encephalopathy, early infantile, 1; eiee1,myelination, delayed, with ataxia; mda,ventriculomegaly, congenital; vmg,arthrogryposis, distal, with cardiac arrhythmia; da-ca,epileptic encephalopathy, early infantile, 2; eiee2","arthrogryposis, distal, type 1a; da1a,arthrogryposis, distal, type 2b1; da2b1,arthrogryposis, distal, type 5d; da5d,arthrogryposis, distal, type 9; da9,arthrogryposis, distal, type 10; da10,arthrogryposis, distal, type 11; da11,arthrogryposis, distal, type 12; da12,arthrogryposis, distal, type 13; da13,arthrogryposis, distal, type 14; da14,arthrogryposis, distal, type 15; da15,arthrogryposis, distal, type 16; da16,arthrogryposis, distal, type 17; da17,arthrogryposis, distal, type 18; da18,arthrogryposis, distal, type 19; da19,arthrogryposis, distal, type 20; da20,arthrogryposis, distal, type 21; da21,arthrogryposis, distal, type 22; da22,arthrogryposis, distal, type 23; da23,arthrogryposis, distal, type 24; da24,arthrogryposis, distal, type 25; da25",0,0,"hyperekplexia and epilepsy; hkpx,arthrogryposis, mental retardation, and seizures; amrs,epileptic encephalopathy, early infantile, 4; eiee4,arthrogryposis multiplex congenita, neurogenic, with myelin defect,congenital central hypoventilation syndrome; cchs,epileptic encephalopathy, early infantile, 2; eiee2,arthrogryposis multiplex congenita, neurogenic type; amcn,spinal muscular atrophy with respiratory distress 1; smard1,glycine encephalopathy; gce,lethal congenital contracture syndrome 1; lccs1","arthrogryposis, congenital myasthenic syndrome with,hyperekplexia, hereditary 1; hkpx1,arthrogryposis multiplex congenita, neurogenic type,congenital central hypoventilation syndrome; cchs,epileptic encephalopathy, early infantile, 1; eiee1,arthrogryposis multiplex congenita, neurogenic, with myelin defect,myasthenic syndrome, congenital, 8; cms8,spinal muscular atrophy, infantile type i; sma1,glycine encephalopathy; gce,arthrogryposis-renal dysfunction-cholestasis syndrome; arcs,epileptic encephalopathy, early infantile, 4; eiee4,myasthenic syndrome, congenital, 11; cms11,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1; camrq1,lethal congenital contracture syndrome 1; lccs1,myasthenic syndrome, congenital, 10; cms10,epileptic encephalopathy, early infantile, 2; eiee2,arthrogryposis multiplex congenita, neurogenic, x-linked,brain small vessel disease with or without ocular anomalies,corpus callosum, agenesis of, with abnormal genitalia,myasthenic syndrome, congenital, 6; cms6",0,0
Hypotonia; Global developmental delay; Feeding difficulties; Intellectual disability; Delayed motor milestones; Delayed language development; Characteristic facies; Simian crease; Weak cry,PRADER-WILLI SYNDROME; PWS,"angelman syndrome,prader-willi syndrome,smith-magenis syndrome,williams-beuren syndrome,pitt-hopkins syndrome,rubinstein-taybi syndrome,mowat-wilson syndrome,cohen syndrome,kabuki syndrome 1,cornelia de lange syndrome 1","angelman syndrome,prader-willi syndrome,smith-magenis syndrome,williams-beuren syndrome,rubinstein-taybi syndrome,phelan-mcdermid syndrome,mowat-wilson syndrome,sotos syndrome 1,kabuki syndrome 1,coffin-lowry syndrome,cornelia de lange syndrome 1,chromosome 22q11.2 deletion syndrome,chromosome 15q11-q13 duplication syndrome,chromosome 1p36 deletion syndrome,chromosome 17p13.3 deletion syndrome,chromosome 4p16.3 deletion syndrome,chromosome 5p15.2 deletion syndrome,chromosome 7q11.23 duplication syndrome,chromosome 16p11.2 deletion syndrome,chromosome 16p11.2 duplication syndrome",1,1,"mental retardation, autosomal recessive 58; mrt58,hypotonia, infantile, with psychomotor retardation and characteristic facies 1; ihprf1,mental retardation, autosomal dominant 54; mrd54,chromosome 1p36 deletion syndrome,pitt-hopkins syndrome; pths,angelman syndrome; as,mental retardation, x-linked, syndromic 13; mrxs13,mental retardation, autosomal recessive 13; mrt13,hypotonia-cystinuria syndrome; hycys,mental retardation and distinctive facial features with or without cardiac defects","mental retardation, autosomal recessive 58; mrt58,hypotonia, infantile, with psychomotor retardation and characteristic facies 1; ihprf1,mental retardation, autosomal recessive 13; mrt13,chromosome 1p36 deletion syndrome,pitt-hopkins syndrome; pths,angelman syndrome; as,prader-willi syndrome; pws,mental retardation, autosomal recessive 3; mrt3,hypotonia-cystinuria syndrome; hycs,mental retardation and distinctive facial features with or without cardiac defects,mental retardation, x-linked 30; mrx30,mental retardation, x-linked 45; mrx45,chromosome 22q13.3 deletion syndrome,mental retardation, autosomal dominant 51; mrd51,hypotonia, infantile, with psychomotor retardation and characteristic facies 2; ihprf2,mental retardation, x-linked 72; mrx72,chromosome 2q37 deletion syndrome,mental retardation, autosomal recessive 62; mrt62,mental retardation and distinctive facial features with or without urogenital defects,mental retardation, x-linked 21; mrx21",0,1
Global developmental delay; Intellectual disability; Epilepsy; Dysphonia; Macrocephaly; Hypotonia; Delayed speech; Motor development delay; Abnormal facial shape; Hypsarrhythmia,O'DONNELL-LURIA-RODAN SYNDROME; ODLURO,"megalencephaly-capillary malformation-polymicrogyria syndrome; mcap,west syndrome,angelman syndrome,sotos syndrome 1,phelan-mcdermid syndrome,tuberous sclerosis 1; tsc1,smith-magenis syndrome,pten hamartoma tumor syndrome,mowat-wilson syndrome,foxg1 syndrome","angelman syndrome,phelan-mcdermid syndrome,smith-magenis syndrome,sotos syndrome 1,mowat-wilson syndrome,rubinstein-taybi syndrome 1,tuberous sclerosis 1,cowden syndrome 1,pten hamartoma tumor syndrome,mecp2 duplication syndrome,foxg1 syndrome,pitt-hopkins syndrome,syngap1-related intellectual disability,kleefstra syndrome 1,sturge-weber syndrome,dravet syndrome,cdkl5 deficiency disorder,jacoboud-syndrome,kabuki syndrome 1,weaver syndrome",0,0,"epileptic encephalopathy, early infantile, 4; eiee4,developmental and epileptic encephalopathy 85; dee85,mental retardation, autosomal dominant 51; mrd51,developmental and epileptic encephalopathy 5; dee5,epileptic encephalopathy, early infantile, 2; eiee2,mental retardation, autosomal recessive 62; mrt62,developmental and epileptic encephalopathy 28; dee28,mental retardation, autosomal dominant 54; mrd54,developmental and epileptic encephalopathy 31; dee31,mental retardation, x-linked, syndromic, christianson type; mrxsch","epileptic encephalopathy, early infantile, 4; eiee4,mental retardation, autosomal dominant 54; mrd54,epileptic encephalopathy, early infantile, 2; eiee2,developmental and epileptic encephalopathy 85; dee85,mental retardation, autosomal dominant 51; mrd51,developmental and epileptic encephalopathy 95; dee95,epileptic encephalopathy, early infantile, 25; eiee25,mental retardation, autosomal recessive 62; mrt62,developmental and epileptic encephalopathy 89; dee89,mental retardation, autosomal dominant 50; mrd50,developmental and epileptic encephalopathy 84; dee84,epileptic encephalopathy, early infantile, 14; eiee14,developmental and epileptic encephalopathy 90; dee90,mental retardation, x-linked 102; mrx102,developmental and epileptic encephalopathy 87; dee87,megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1; mpph1,developmental and epileptic encephalopathy 83; dee83,mental retardation, autosomal dominant 57; mrd57,epileptic encephalopathy, early infantile, 11; eiee11,developmental and epileptic encephalopathy 86; dee86",0,0
Global developmental delay; Intellectual disability; Behavioral disorders; Attention-deficit/hyperactivity disorder; Autism spectrum disorder; Oppositional defiant disorder; Mixed language disorder; Developmental coordination disorder,GNB1 encephalopathy,"autism, susceptibility to, x-linked 3; autsx3,mental retardation, x-linked, syndromic, turner type; mrxst,mental retardation, x-linked, syndromic, claes-jensen type; mrxsj,mental retardation, autosomal dominant 1; mrd1,mental retardation, autosomal dominant 2; mrd2,mental retardation, autosomal dominant 3; mrd3,mental retardation, autosomal dominant 4; mrd4,mental retardation, autosomal dominant 5; mrd5,mental retardation, autosomal dominant 6; mrd6,mental retardation, autosomal dominant 7; mrd7","angelman syndrome,fragile x syndrome,rett syndrome,smith-magenis syndrome,williams-beuren syndrome,prader-willi syndrome,pitt-hopkins syndrome,rubinstein-taybi syndrome,sotos syndrome 1,mowat-wilson syndrome,tuberous sclerosis 1,neurofibromatosis, type i,phelan-mcdermid syndrome,kabuki syndrome 1,cohen syndrome,cornelia de lange syndrome 1,smith-lemli-opitz syndrome,sanfilippo syndrome a,lissencephaly 1,x-linked intellectual disability, syndromic, claes-jensen type",0,0,"mental retardation, autosomal dominant 54; mrd54,mental retardation, autosomal dominant 51; mrd51,developmental and epileptic encephalopathy 95; dee95,mental retardation, autosomal recessive 62; mrt62,mental retardation, x-linked 102; mrx102,developmental and epileptic encephalopathy 84; dee84,mental retardation, autosomal dominant 57; mrd57,autism, susceptibility to, 1; auts1,mental retardation, x-linked, syndromic, nascimento type; mrxsn,mental retardation, autosomal dominant 50; mrd50","mental retardation, autosomal dominant 54; mrd54,mental retardation, autosomal dominant 51; mrd51,developmental and epileptic encephalopathy 95; dee95,mental retardation, autosomal recessive 62; mrt62,mental retardation, x-linked 102; mrx102,developmental and epileptic encephalopathy 84; dee84,mental retardation, autosomal dominant 57; mrd57,autism, susceptibility to, 1; auts1,mental retardation, x-linked 93; mrx93,developmental and epileptic encephalopathy 85; dee85,mental retardation, autosomal dominant 50; mrd50,mental retardation, x-linked 30; mrx30,mental retardation, autosomal recessive 44; mrt44,developmental delay with autism spectrum disorder; ddaut,mental retardation, x-linked 72; mrx72,mental retardation, autosomal dominant 56; mrd56,developmental and epileptic encephalopathy 89; dee89,mental retardation, x-linked, syndromic 14; mrxs14,mental retardation, autosomal dominant 55; mrd55,autism, susceptibility to, 2; auts2",0,0
Congenital microcephaly; Severe intellectual disability; Intractable seizures; Refractory epileptic gaze; Unilateral tonic-clonic seizures; Brain atrophy; Delayed psychomotor development; Hyperactivity; Agitation; Open-mouth posture,ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD,"microcephaly, epilepsy, and diabetes syndrome; meds,microcephaly, epilepsy, and diabetes syndrome 2; meds2,epileptic encephalopathy, early infantile, 1; eiee1,epileptic encephalopathy, early infantile, 2; eiee2,epileptic encephalopathy, early infantile, 3; eiee3,epileptic encephalopathy, early infantile, 4; eiee4,epileptic encephalopathy, early infantile, 5; eiee5,epileptic encephalopathy, early infantile, 6; eiee6,epileptic encephalopathy, early infantile, 7; eiee7,epileptic encephalopathy, early infantile, 8; eiee8","microcephaly, epilepsy, and diabetes syndrome; meds,microcephaly, epilepsy, and diabetes syndrome 2; meds2,microcephaly, epilepsy, and diabetes syndrome 3; meds3,epileptic encephalopathy, early infantile, 1; eiee1,epileptic encephalopathy, early infantile, 2; eiee2,epileptic encephalopathy, early infantile, 3; eiee3,epileptic encephalopathy, early infantile, 4; eiee4,epileptic encephalopathy, early infantile, 5; eiee5,epileptic encephalopathy, early infantile, 6; eiee6,epileptic encephalopathy, early infantile, 7; eiee7,epileptic encephalopathy, early infantile, 8; eiee8,epileptic encephalopathy, early infantile, 9; eiee9,epileptic encephalopathy, early infantile, 10; eiee10,epileptic encephalopathy, early infantile, 11; eiee11,epileptic encephalopathy, early infantile, 12; eiee12,epileptic encephalopathy, early infantile, 13; eiee13,epileptic encephalopathy, early infantile, 14; eiee14,epileptic encephalopathy, early infantile, 15; eiee15,epileptic encephalopathy, early infantile, 16; eiee16,epileptic encephalopathy, early infantile, 17; eiee17",0,0,"epileptic encephalopathy, early infantile, 4; eiee4,microcephaly, primary, with seizures; mcsz,epileptic encephalopathy, early infantile, 5; eiee5,developmental and epileptic encephalopathy 95; dee95,microcephaly-seizures syndrome; mcsz,epileptic encephalopathy, early infantile, 25; eiee25,developmental and epileptic encephalopathy 85; dee85,microcephaly, primary, autosomal recessive, 1; mcph1,developmental and epileptic encephalopathy 28; dee28,epileptic encephalopathy, early infantile, 14; eiee14","epileptic encephalopathy, early infantile, 4; eiee4,microcephaly, primary, with seizures; mcsz,epileptic encephalopathy, early infantile, 5; eiee5,developmental and epileptic encephalopathy 85; dee85,microcephaly 1, primary, autosomal recessive; mcph1,epileptic encephalopathy, early infantile, 6; eiee6,developmental and epileptic encephalopathy 95; dee95,developmental and epileptic encephalopathy 89; dee89,microcephaly, seizures, and developmental delay; mcsdd,epileptic encephalopathy, early infantile, 13; eiee13,developmental and epileptic encephalopathy 90; dee90,microcephaly with seizures; mcsz,developmental and epileptic encephalopathy 51; dee51,epileptic encephalopathy, early infantile, 14; eiee14,developmental and epileptic encephalopathy 86; dee86,microcephaly 3, primary, autosomal recessive; mcph3,developmental and epileptic encephalopathy 87; dee87,epileptic encephalopathy, early infantile, 25; eiee25,developmental and epileptic encephalopathy 93; dee93,microcephaly 5, primary, autosomal recessive; mcph5",0,0
Distal muscle weakness; Muscle atrophy; Claw hand; Pes cavus; Absent Achilles reflexes; Foot drop; High steppage gait; Bilateral hand weakness; Contracture of the Achilles tendon,Charcot-Marie-Tooth disease,"charcot-marie-tooth disease, type 1a,charcot-marie-tooth disease, type 1b,charcot-marie-tooth disease, type 2a1,charcot-marie-tooth disease, type 2b,charcot-marie-tooth disease, type 2c,charcot-marie-tooth disease, type 2d,charcot-marie-tooth disease, type 4a,charcot-marie-tooth disease, type 4b1,charcot-marie-tooth disease, type 4c,charcot-marie-tooth disease, x-linked, type 1","charcot-marie-tooth disease, type 1a,charcot-marie-tooth disease, type 1b,charcot-marie-tooth disease, type 2a1,charcot-marie-tooth disease, type 2b1,charcot-marie-tooth disease, type 2c,charcot-marie-tooth disease, type 2d,charcot-marie-tooth disease, type 2e,charcot-marie-tooth disease, type 2f,charcot-marie-tooth disease, type 2g,charcot-marie-tooth disease, type 2i,charcot-marie-tooth disease, type 2j,charcot-marie-tooth disease, type 2k,charcot-marie-tooth disease, type 2l,charcot-marie-tooth disease, type 2m,charcot-marie-tooth disease, type 2n,charcot-marie-tooth disease, type 2o,charcot-marie-tooth disease, type 2p,charcot-marie-tooth disease, type 2q,charcot-marie-tooth disease, type 2r,charcot-marie-tooth disease, type 2s",1,1,"charcot-marie-tooth disease, type 1a; cmt1a,charcot-marie-tooth disease, type 1b; cmt1b,charcot-marie-tooth disease, axonal, type 2a1; cmt2a1,hereditary motor and sensory neuropathy iia; hmsn2a,charcot-marie-tooth disease, x-linked dominant, 1; cmtx1,hereditary motor and sensory neuropathy, type iib; hmsn2b,distal hereditary motor neuronopathy, type 2a; dhmn2a,spinal muscular atrophy, distal, autosomal recessive, 1; dsma1,hereditary motor and sensory neuropathy iv; hmsn4,charcot-marie-tooth disease, type 4a; cmt4a","charcot-marie-tooth disease, type 1a; cmt1a,charcot-marie-tooth disease, type 1b; cmt1b,charcot-marie-tooth disease, type 2a1; cmt2a1,charcot-marie-tooth disease, type 2b; cmt2b,charcot-marie-tooth disease, type 4a; cmt4a,hereditary motor and sensory neuropathy, type iia; hmsn2a,hereditary motor and sensory neuropathy, type iib; hmsn2b,distal hereditary motor neuronopathy, type va; dhmn5a,distal hereditary motor neuronopathy, type vb; dhmn5b,spinal muscular atrophy, distal, autosomal recessive, 1; dsma1,hereditary sensory and autonomic neuropathy, type iia; hsan2a,neuropathy, hereditary motor and sensory, type via; hmsn6a,neuropathy, congenital hypomyelinating, 1; chn1,dejerine-sottas syndrome; dss,neuropathy, hereditary motor and sensory, russe type; hmsnr,spinal muscular atrophy, distal, autosomal dominant, 3; dsma3,neuropathy, hereditary motor, type vb; hmn5b,neuropathy, hereditary motor and sensory, type iic; hmsn2c,neuropathy, hereditary motor and sens",1,1
Rest tremor; Rigidity; Bradykinesia; Constipation; Hyposmia; Rapid eye movement sleep behavior disorder; Hypomimia; Hypophonia; Orthostatic hypotension,Parkinson disease,"parkinson disease 1; park1,parkinson disease 2, autosomal recessive; park2,parkinson disease 3; park3,parkinson disease 4, autosomal dominant; park4,parkinson disease 5, autosomal recessive; park5,parkinson disease 6, autosomal recessive; park6,parkinson disease 7, autosomal recessive; park7,parkinson disease 8, autosomal dominant; park8,parkinson disease 9, autosomal dominant; park9,parkinson disease 10, autosomal dominant; park10","parkinson disease 1; park1,parkinson disease 2, autosomal recessive; park2,parkinson disease 3; park3,parkinson disease 4, autosomal dominant; park4,parkinson disease 5, autosomal recessive; park5,parkinson disease 6, autosomal recessive, early-onset; park6,parkinson disease 7, autosomal recessive, early-onset; park7,parkinson disease 8; park8,parkinson disease 9; park9,parkinson disease 10; park10,parkinson disease 11; park11,parkinson disease 12, autosomal dominant; park12,parkinson disease 13, autosomal dominant; park13,parkinson disease 14, autosomal recessive, early-onset; park14,parkinson disease 15, autosomal recessive, early-onset; park15,parkinson disease 16, autosomal recessive, early-onset; park16,parkinson disease 17, autosomal dominant; park17,parkinson disease 18, autosomal recessive, early-onset; park18,parkinson disease 19, autosomal dominant; park19,parkinson disease 20, autosomal recessive, early-onset; park20",1,1,"parkinson disease 1, autosomal dominant; park1,parkinson disease 4, autosomal dominant; park4,parkinson disease 8, autosomal dominant; park8,multiple system atrophy 1; msa1,neurodegeneration with brain iron accumulation 1; nbia1,parkinson disease 2, autosomal recessive juvenile; park2,parkinson disease 6, autosomal recessive early-onset; park6,kufor-rakeb syndrome; krs,perry syndrome,frontotemporal dementia and parkinsonism; ftdp","parkinson disease 1, autosomal dominant; park1,parkinson disease 2, autosomal recessive; park2,parkinson disease 4, autosomal dominant; park4,parkinson disease 6, autosomal recessive; park6,parkinson disease 7, autosomal recessive; park7,parkinson disease 8, autosomal dominant; park8,parkinson disease 9; park9,parkinson disease 15, autosomal recessive; park15,parkinson disease 17; park17,parkinson disease 19, early-onset; park19,parkinson disease 20, early-onset; park20,parkinson disease 21; park21,parkinson disease 23; park23,multiple system atrophy 1; msa1,neurodegeneration with brain iron accumulation 1; nbia1,dystonia-parkinsonism, rapid-onset; dyt12,perry syndrome,frontotemporal dementia and parkinsonism; ftdp,lewy body dementia; lbd,neurodegeneration with brain iron accumulation 2a; nbia2a",1,1
Neurodevelopmental disability; Dysmorphic traits; Chorea; Dystonia; Ataxia; Developmental delay; Central hypotonia; Mild intellectual disability; Severe dysphonia; Cerebellar dysarthria,FRA12A-type intellectual disability,"neurodegeneration with brain iron accumulation 1; nbia1,neurodegeneration with brain iron accumulation 2a; nbia2a,neurodegeneration with brain iron accumulation 2b; nbia2b,neurodegeneration with brain iron accumulation 3; nbia3,neurodegeneration with brain iron accumulation 4; nbia4,neurodegeneration with brain iron accumulation 5; nbia5,neurodegeneration with brain iron accumulation 6; nbia6,neurodegeneration with brain iron accumulation 7; nbia7,neurodegeneration with brain iron accumulation 8; nbia8,neurodegeneration with brain iron accumulation 9; nbia9","neurodegeneration with brain iron accumulation 1; nbia1,huntington disease-like syndrome,neurodegeneration with brain iron accumulation 2a; nbia2a,neurodegeneration with brain iron accumulation 4; nbia4,neurodegeneration with brain iron accumulation 5; nbia5,neurodegeneration with brain iron accumulation 6; nbia6,neurodegeneration with brain iron accumulation 7; nbia7,neurodegeneration with brain iron accumulation 8; nbia8,neurodegeneration with brain iron accumulation 9; nbia9,neurodegeneration with brain iron accumulation 10; nbia10,neurodegeneration with brain iron accumulation 11; nbia11,neurodegeneration with brain iron accumulation 12; nbia12,neurodegeneration with brain iron accumulation 13; nbia13,neurodegeneration with brain iron accumulation 14; nbia14,neurodegeneration with brain iron accumulation 15; nbia15,neurodegeneration with brain iron accumulation 16; nbia16,neurodegeneration with brain iron accumulation 17; nbia17,neurodegeneration with brain iron accumulation 18; nbia18,neurodegeneration with brain iron accumulation 19; nbia19,neurodegeneration with brain iron accumulation 20; nbia20",0,0,"cerebellar ataxia, developmental delay, and seizures; caddys,ataxia-choreoathetosis-dystonia syndrome; atxchdys,developmental and epileptic encephalopathy 82; dee82,spinocerebellar ataxia, autosomal recessive 16; scar16,dystonia 28, childhood-onset; dyt28,neurodevelopmental disorder with cerebellar atrophy; nddca,ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia; eaoh,cerebellar ataxia and hypogonadotropic hypogonadism; cahh,neurodevelopmental disorder with hypotonia and cerebellar atrophy; nedhca,spinocerebellar ataxia, autosomal recessive 14; scar14","ataxia-telangiectasia; at,cerebellar ataxia, developmental delay, and seizures; caddys,spinocerebellar ataxia 29; sca29,joubert syndrome 1; jbts1,dystonia 4, torsion, autosomal dominant; dyt4,neurodegeneration with brain iron accumulation 1; nbia1,ataxia with oculomotor apraxia 1; aoa1,cerebellar ataxia and hypogonadotropic hypogonadism; cahh,pontocerebellar hypoplasia, type 1a; pch1a,spinocerebellar ataxia, autosomal recessive 8; scar8,chorea, childhood-onset, with psychomotor retardation,ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia; eaoh,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1; camrq1,dystonia-ataxia syndrome due to beta-propeller protein-associated neurodegeneration,spastic ataxia 1, autosomal dominant; spax1,cerebellar ataxia and mental retardation with or without quadrupedal locomotion 2; camrq2,huntington disease-like 2; hdl2,ataxia-pancytopenia syndrome; atxpc,spinocerebellar ataxia with axonal neuropathy 1; scan1,cerebellar ataxia,",0,0
Cerebellar ataxia; Oculomotor apraxia; Dysarthria; Peripheral axonal neuropathy; Hypoalbuminemia; Telangiectasia; Intention tremor; Dysmetria; Dysdiadochokinesia,Ataxia with oculomotor apraxia type 1,"ataxia-telangiectasia,ataxia with oculomotor apraxia type 1; aoa1,ataxia with oculomotor apraxia type 2; aoa2,spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scar1,spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2; scar2,spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3; scar3,spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 4; scar4,spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 5; scar5,spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 6; scar6,spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 7; scar7","ataxia-telangiectasia,ataxia with oculomotor apraxia type 1,ataxia with oculomotor apraxia type 2,spinocerebellar ataxia type 1,spinocerebellar ataxia type 2,spinocerebellar ataxia type 3,spinocerebellar ataxia type 6,spinocerebellar ataxia type 7,spinocerebellar ataxia type 17,friedreich ataxia,charcot-marie-tooth disease, axonal, type 2a1,charcot-marie-tooth disease, axonal, type 2b1,charcot-marie-tooth disease, axonal, type 2c,charcot-marie-tooth disease, axonal, type 2d,charcot-marie-tooth disease, axonal, type 2e,charcot-marie-tooth disease, axonal, type 2f,charcot-marie-tooth disease, axonal, type 2g,charcot-marie-tooth disease, axonal, type 2i,charcot-marie-tooth disease, axonal, type 2j,charcot-marie-tooth disease, axonal, type 2k",1,1,"ataxia with oculomotor apraxia type 1; aoa1,ataxia with oculomotor apraxia type 2; aoa2,ataxia-telangiectasia; at,spinocerebellar ataxia, autosomal recessive 9; scar9,ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia; eaoh,cerebellar ataxia, neuropathy, and vestibular areflexia syndrome; canvas,spinocerebellar ataxia 2; sca2,ataxia-telangiectasia-like disorder; atld,spinocerebellar ataxia, autosomal recessive 8; scar8,cerebellar ataxia and hypogonadism; cahg","ataxia with oculomotor apraxia type 1; aoa1,ataxia-telangiectasia; at,ataxia with oculomotor apraxia type 2; aoa2,ataxia with oculomotor apraxia type 4; aoa4,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,friedreich ataxia 1; frda1,spinocerebellar ataxia 1; sca1,ataxia with oculomotor apraxia type 3; aoa3,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 6; sca6,cerebellar ataxia, neuropathy, and vestibular areflexia syndrome; canvas,ataxia-telangiectasia-like disorder; atld,spinocerebellar ataxia 8; sca8,spinocerebellar ataxia 28; sca28,cerebellar ataxia and hypogonadotropic hypogonadism; cahh,ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia; eaoh,spinocerebellar ataxia 5; sca5,spinocerebellar ataxia 13; sca13,spinocerebellar ataxia 14; sca14",1,1
Lower limb weakness; Low back pain; Difficulty standing after squatting; Difficulty climbing stairs; Gowers' sign; Proximal muscle weakness; Weakened tendon reflexes in lower limbs; Increased creatine kinase; Iron deficiency anemia,Limb-girdle muscular dystrophy 2B,"muscular dystrophy, duchenne type,muscular dystrophy, becker type,limb-girdle muscular dystrophy, type 2a,limb-girdle muscular dystrophy, type 2b,limb-girdle muscular dystrophy, type 2c,limb-girdle muscular dystrophy, type 2d,limb-girdle muscular dystrophy, type 2e,limb-girdle muscular dystrophy, type 2f,limb-girdle muscular dystrophy, type 2g,limb-girdle muscular dystrophy, type 2h","muscular dystrophy, duchenne type,muscular dystrophy, becker type,limb-girdle muscular dystrophy, type 2a,limb-girdle muscular dystrophy, type 2b,limb-girdle muscular dystrophy, type 2c,limb-girdle muscular dystrophy, type 2d,limb-girdle muscular dystrophy, type 2e,limb-girdle muscular dystrophy, type 2f,limb-girdle muscular dystrophy, type 2g,limb-girdle muscular dystrophy, type 2h,limb-girdle muscular dystrophy, type 2i,limb-girdle muscular dystrophy, type 2j,limb-girdle muscular dystrophy, type 2k,limb-girdle muscular dystrophy, type 2l,limb-girdle muscular dystrophy, type 2m,limb-girdle muscular dystrophy, type 2n,limb-girdle muscular dystrophy, type 2o,limb-girdle muscular dystrophy, type 2p,limb-girdle muscular dystrophy, type 2q,limb-girdle muscular dystrophy, type 2r",0,0,"muscular dystrophy, limb-girdle, type 2i; lgmd2i,muscular dystrophy, duchenne type; dmd,muscular dystrophy, becker type; bmd,muscular dystrophy, limb-girdle, type 2a; lgmd2a,muscular dystrophy, limb-girdle, type 2b; lgmd2b,muscular dystrophy, limb-girdle, type 2d; lgmd2d,myopathy, myofibrillar, 1; mfm1,myopathy, centronuclear, 1; cnm1,spinal muscular atrophy, type iii; sma3,pompe disease, late-onset; lopd","muscular dystrophy, limb-girdle, type 2i; lgmd2i,muscular dystrophy, duchenne type; dmd,muscular dystrophy, becker type; bmd,muscular dystrophy, limb-girdle, type 2a; lgmd2a,muscular dystrophy, limb-girdle, type 2b; lgmd2b,muscular dystrophy, limb-girdle, type 2d; lgmd2d,muscular dystrophy, congenital, type 1a; mdc1a,myopathy, myofibrillar, 1; mfm1,myopathy, centronuclear, 1; cnm1,pompe disease, late-onset; lopd,spinal muscular atrophy, type iii; sma3,myopathy, congenital, with fiber-type disproportion; cftd,muscular dystrophy, emery-dreifuss, 1; edmd1,muscular dystrophy, limb-girdle, type 2c; lgmd2c,myopathy, distal, 1; mpd1,nemaline myopathy 1; nem1,myopathy, bethlem; bthlm,muscular dystrophy, congenital, ullrich type; ucmd,myopathy, early-onset, with fatal cardiomyopathy; mpxmp,muscular dystrophy, facioscapulohumeral, 1; fshd",0,0
Bradykinesia; Tremor; Dystonia; Gait imbalance; Cognitive regression; Stiffness; Hypomimia; Increased muscle tone,PLA2G6-related dystonia-parkinsonism complex,"parkinson disease 1; park1,dystonia 1, torsion; dyt1,parkinsonism-dystonia, juvenile-onset; parkinsonism-dystonia,parkinson disease 2, autosomal recessive, juvenile; park2,dystonia 6, torsion; dyt6,parkinsonism, autosomal recessive, with spiking rema; parkinsonism-ar,dystonia 12; dyt12,parkinsonism, autosomal dominant, susceptibility to; parkinsonism-ad,dystonia 25, torsion; dyt25,parkinsonism, early-onset, with diabetes; parkinsonism-diabetes","parkinson disease 1, autosomal dominant; park1,parkinson disease 2, autosomal recessive; park2,parkinson disease 3, autosomal dominant; park3,parkinson disease 4, autosomal dominant; park4,parkinson disease 5, autosomal recessive; park5,parkinson disease 6, autosomal recessive, early-onset; park6,parkinson disease 7, autosomal recessive, early-onset; park7,parkinson disease 8, autosomal dominant; park8,parkinson disease 9, autosomal dominant; park9,parkinson disease 10, autosomal dominant; park10,parkinson disease 11, autosomal recessive; park11,parkinson disease 12, autosomal dominant; park12,parkinson disease 13, autosomal dominant; park13,parkinson disease 14, autosomal recessive, early-onset; park14,parkinson disease 15, autosomal recessive, juvenile; park15,parkinson disease 16, autosomal recessive, juvenile; park16,parkinson disease 17, autosomal dominant; park17,parkinson disease 18, autosomal dominant; park18,parkinson disease 19, autosomal dominant; park19,parkinson disease 20, autosomal dominant; park20",0,0,"parkinson disease 1, autosomal dominant; park1,dystonia-parkinsonism, early-onset; dyt-park,neurodegeneration with brain iron accumulation 1; nbia1,parkinson disease 2, autosomal recessive juvenile; park2,kufor-rakeb syndrome; krs,neurodegeneration with brain iron accumulation 2a; nbia2a,dystonia 5; dyt5,parkinson disease 6, autosomal recessive early-onset; park6,rapid-onset dystonia-parkinsonism; rdp,wilson disease; wnd","parkinson disease 1, autosomal dominant; park1,dystonia-parkinsonism, early-onset; dyt-park,neurodegeneration with brain iron accumulation 1; nbia1,kufor-rakeb syndrome; krs,parkinson disease 2, autosomal recessive juvenile; park2,dystonia 5; dyt5,neurodegeneration with brain iron accumulation 2a; nbia2a,wilson disease; wnd,huntington disease-like 2; hdl2,dystonia 16; dyt16,parkinson disease 6, autosomal recessive early-onset; park6,neurodegeneration with brain iron accumulation 4; nbia4,niemann-pick disease, type c1; npc1,pantothenate kinase-associated neurodegeneration; pkan,dystonia 3, torsion, x-linked; dyt3,parkinson disease 7, autosomal recessive early-onset; park7,rapid-onset dystonia-parkinsonism; rdp,neurodegeneration with brain iron accumulation 3; nbia3,dystonia-parkinsonism, x-linked; xdp,mitochondrial complex i deficiency, nuclear type 4; mc1dn4",0,0
Global developmental delay; Intellectual disability; Language delay; Autistic features; Epilepsy; Behavioral problems; Facial dysmorphism; Hyperkinetic movement disorder; Flat angiomas; Choanal atresia,FOXP1-related intellectual disability syndrome,"charge syndrome,angelman syndrome,pitt-hopkins syndrome,mowat-wilson syndrome,smith-magenis syndrome,rubinstein-taybi syndrome,foxg1 syndrome,syngap1-related intellectual disability,satb2-associated syndrome,kleefstra syndrome","angelman syndrome,rett syndrome,smith-magenis syndrome,pitt-hopkins syndrome,mowat-wilson syndrome,rubinstein-taybi syndrome,foxg1 syndrome,phelan-mcdermid syndrome,tuberous sclerosis 1; tsc1,tuberous sclerosis 2; tsc2,sturge-weber syndrome,cowden syndrome,noonan syndrome,williams-beuren syndrome,fragile x syndrome,prader-willi syndrome,smith-lemli-opitz syndrome,charge syndrome,kabuki syndrome 1,kabuki syndrome 2",0,0,"mental retardation, autosomal dominant 54; mrd54,epileptic encephalopathy, early infantile, 4; eiee4,mental retardation, autosomal recessive 41; mrt41,developmental and epileptic encephalopathy 95; dee95,mental retardation, autosomal dominant 51; mrd51,epileptic encephalopathy, early infantile, 9; eiee9,developmental and epileptic encephalopathy 85; dee85,mental retardation, autosomal dominant 50; mrd50,developmental and epileptic encephalopathy 28; dee28,mental retardation, x-linked, syndromic, christianson type; mrxsch","mental retardation, autosomal dominant 54; mrd54,epileptic encephalopathy, early infantile, 4; eiee4,mental retardation, autosomal dominant 51; mrd51,developmental and epileptic encephalopathy 95; dee95,mental retardation, autosomal dominant 50; mrd50,epileptic encephalopathy, early infantile, 9; eiee9,charge syndrome,pitt-hopkins syndrome,mental retardation, autosomal dominant 47; mrd47,developmental and epileptic encephalopathy 85; dee85,angelman syndrome,christianson syndrome,mental retardation, autosomal recessive 58; mrt58,kleefstra syndrome 1,developmental and epileptic encephalopathy 28; dee28,mental retardation, autosomal dominant 43; mrd43,coffin-siris syndrome 1; css1,kabuki syndrome 1; kabuk1,mental retardation, autosomal dominant 42; mrd42,developmental and epileptic encephalopathy 61; dee61",0,0
Seizures; Paroxysmal kinesigenic dyskinesia; Hemiplegic migraine; Focal unaware seizures; Behavioral arrest; Migraine without aura; Tonic-clonic seizures; Focal motor seizures; Febrile seizures; Myoclonic seizures,Benign familial infantile epilepsy,"epilepsy, familial temporal lobe, 1; etl1,epilepsy, familial temporal lobe, 2; etl2,epilepsy, familial temporal lobe, 3; etl3,epilepsy, familial temporal lobe, 4; etl4,epilepsy, familial temporal lobe, 5; etl5,epilepsy, familial temporal lobe, 6; etl6,epilepsy, familial temporal lobe, 7; etl7,epilepsy, familial temporal lobe, 8; etl8,epilepsy, familial temporal lobe, 9; etl9,epilepsy, familial temporal lobe, 10; etl10","epilepsy, familial temporal lobe, 1; etl1,epilepsy, familial temporal lobe, 2; etl2,epilepsy, familial temporal lobe, 3; etl3,epilepsy, familial temporal lobe, 4; etl4,epilepsy, familial temporal lobe, 5; etl5,epilepsy, familial temporal lobe, 6; etl6,epilepsy, familial temporal lobe, 7; etl7,epilepsy, familial temporal lobe, 8; etl8,epilepsy, familial temporal lobe, 9; etl9,epilepsy, familial temporal lobe, 10; etl10,epilepsy, familial temporal lobe, 11; etl11,epilepsy, familial temporal lobe, 12; etl12,epilepsy, familial temporal lobe, 13; etl13,epilepsy, familial temporal lobe, 14; etl14,epilepsy, familial temporal lobe, 15; etl15,epilepsy, familial temporal lobe, 16; etl16,epilepsy, familial temporal lobe, 17; etl17,epilepsy, familial temporal lobe, 18; etl18,epilepsy, familial temporal lobe, 19; etl19,epilepsy, familial temporal lobe, 20; etl20",0,0,"epilepsy, familial focal, with variable foci; ffevf,seizures, benign familial infantile, 1; bfis1,epilepsy, nocturnal frontal lobe, 1; enfl1,migraine, familial hemiplegic, 1; fhm1,epileptic encephalopathy, early infantile, 1; eiee1,seizures, benign familial neonatal-infantile; bfnie,epilepsy, progressive myoclonic, 1a; epm1a,migraine, familial hemiplegic, 2; fhm2,epilepsy, focal, with speech disorder and with or without mental retardation,seizures, benign familial neonatal, 1; bfns1","epilepsy, familial focal, with variable foci; ffevf,seizures, benign familial infantile; bfis,epileptic encephalopathy, early infantile, 14; eiee14,migraine, familial hemiplegic, 1; fhm1,epilepsy, nocturnal frontal lobe, 1; enfl1,seizures, benign familial neonatal-infantile; bfnis,epilepsy, focal, with speech disorder; fesd,migraine, familial hemiplegic, 2; fhm2,epileptic encephalopathy, early infantile, 7; eiee7,epilepsy, generalized, with febrile seizures plus, type 1; gefs+1,epilepsy, progressive myoclonic, 1a; epm1a,migraine, familial hemiplegic, 3; fhm3,epilepsy, focal, with paroxysmal exercise-induced dyskinesia; efped,epileptic encephalopathy, early infantile, 13; eiee13,seizures, benign familial neonatal, 1; bfns1,epilepsy, nocturnal frontal lobe, 4; enfl4,epilepsy, juvenile myoclonic, 1; ejm1,epileptic encephalopathy, early infantile, 16; eiee16,paroxysmal kinesigenic dyskinesia with infantile convulsions; pkd/ic,epilepsy",0,1
Infantile spasms; Drug-resistant epilepsy; Pachygyria; Severe developmental delay; Mental retardation; Hypsarrhythmia; Absence seizures; Poor language skills; Intellectual disability,Pachygyria,"miller-dieker lissencephaly syndrome; mdls,west syndrome,lisencephaly 1; lis1,lisencephaly 2; lis2,lisencephaly 3; lis3,lisencephaly 4; lis4,lisencephaly 5; lis5,lisencephaly 6; lis6,lisencephaly 7; lis7,lisencephaly 8; lis8","west syndrome,lissencephaly 1; lis1,miller-dieker lissencephaly syndrome; mdls,epileptic encephalopathy, early infantile, 1; eiee1,epileptic encephalopathy, early infantile, 2; eiee2,epileptic encephalopathy, early infantile, 3; eiee3,epileptic encephalopathy, early infantile, 4; eiee4,epileptic encephalopathy, early infantile, 5; eiee5,epileptic encephalopathy, early infantile, 6; eiee6,epileptic encephalopathy, early infantile, 7; eiee7,epileptic encephalopathy, early infantile, 8; eiee8,epileptic encephalopathy, early infantile, 9; eiee9,epileptic encephalopathy, early infantile, 10; eiee10,epileptic encephalopathy, early infantile, 11; eiee11,epileptic encephalopathy, early infantile, 12; eiee12,epileptic encephalopathy, early infantile, 13; eiee13,epileptic encephalopathy, early infantile, 14; eiee14,epileptic encephalopathy, early infantile, 15; eiee15,epileptic encephalopathy, early infantile, 16; eiee16,epileptic encephalopathy, early infantile, 17; eiee17",0,0,"epileptic encephalopathy, early infantile, 1; eiee1,lissencephaly 1; lis1,epileptic encephalopathy, early infantile, 2; eiee2,west syndrome, x-linked; wsyx,developmental and epileptic encephalopathy 95; dee95,epileptic encephalopathy, early infantile, 5; eiee5,mental retardation, x-linked, with or without seizures; mrxs,developmental and epileptic encephalopathy 85; dee85,epileptic encephalopathy, early infantile, 14; eiee14,developmental and epileptic encephalopathy 28; dee28","epileptic encephalopathy, early infantile, 1; eiee1,epileptic encephalopathy, early infantile, 2; eiee2,epileptic encephalopathy, early infantile, 4; eiee4,epileptic encephalopathy, early infantile, 6; eiee6,lissencephaly 1; lis1,developmental and epileptic encephalopathy 95; dee95,mental retardation, autosomal recessive 41; mrt41,epileptic encephalopathy, early infantile, 14; eiee14,developmental and epileptic encephalopathy 85; dee85,mental retardation, autosomal recessive 62; mrt62,developmental and epileptic encephalopathy 28; dee28,epileptic encephalopathy, early infantile, 25; eiee25,developmental and epileptic encephalopathy 90; dee90,mental retardation, x-linked 1; mrx1,developmental and epileptic encephalopathy 31; dee31,epileptic encephalopathy, early infantile, 11; eiee11,developmental and epileptic encephalopathy 72; dee72,mental retardation, autosomal dominant 54; mrd54,developmental and epileptic encephalopathy 83; dee83,epileptic encephalopathy, early infantile, 35; eiee35",0,0
Paresthesia; Muscle weakness; Cramps; Hyporeflexia; Pes cavus; Reduced vibration sense; Ataxia; Muscle wasting,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2II; CMT2II","charcot-marie-tooth disease, type 1a,charcot-marie-tooth disease, type 1b,charcot-marie-tooth disease, type 2a1,charcot-marie-tooth disease, type 2c,charcot-marie-tooth disease, type 4a,charcot-marie-tooth disease, type 4b1,charcot-marie-tooth disease, type 4c,charcot-marie-tooth disease, type 4d,charcot-marie-tooth disease, type 4e,charcot-marie-tooth disease, type 4f","charcot-marie-tooth disease, type 1a,charcot-marie-tooth disease, type 1b,charcot-marie-tooth disease, type 2a1,charcot-marie-tooth disease, type 2b,charcot-marie-tooth disease, type 2c,charcot-marie-tooth disease, type 2d,charcot-marie-tooth disease, type 2e,charcot-marie-tooth disease, type 2f,charcot-marie-tooth disease, type 2g,charcot-marie-tooth disease, type 2i,charcot-marie-tooth disease, type 2j,charcot-marie-tooth disease, type 2k,charcot-marie-tooth disease, type 2l,charcot-marie-tooth disease, type 2m,charcot-marie-tooth disease, type 2n,charcot-marie-tooth disease, type 2o,charcot-marie-tooth disease, type 2p,charcot-marie-tooth disease, type 2q,charcot-marie-tooth disease, type 2r,charcot-marie-tooth disease, type 2s",1,1,"charcot-marie-tooth disease, type 1a; cmt1a,hereditary sensory and autonomic neuropathy type 1; hsan1,charcot-marie-tooth disease, type 1b; cmt1b,hereditary motor and sensory neuropathy type 2a; hmsn2a,spinocerebellar ataxia 1; sca1,friedreich ataxia 1; frda,charcot-marie-tooth disease, axonal, type 2k; cmt2k,dejerine-sottas disease; dsd,hereditary neuropathy with liability to pressure palsies; hnpp,charcot-marie-tooth disease, x-linked dominant, 1; cmtx1","charcot-marie-tooth disease, type 1a; cmt1a,charcot-marie-tooth disease, type 1b; cmt1b,charcot-marie-tooth disease, type 2a1; cmt2a1,hereditary sensory and autonomic neuropathy, type 1a; hsan1a,spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,friedreich ataxia 1; frda1,dejerine-sottas disease; dss,hereditary motor and sensory neuropathy, type iia; hmsn2a,hereditary neuropathy with liability to pressure palsies; hnpp,charcot-marie-tooth disease, type 4a; cmt4a,spinocerebellar ataxia 3; sca3,hereditary motor and sensory neuropathy, type iib; hmsn2b,charcot-marie-tooth disease, type x1; cmtx1,spinocerebellar ataxia 6; sca6,charcot-marie-tooth disease, type 4c; cmt4c,hereditary sensory and autonomic neuropathy, type 2a; hsan2a,spinocerebellar ataxia 7; sca7,charcot-marie-tooth disease, type 2b; cmt2b,hereditary motor and sensory neuropathy, type vi; hmsn6",1,1
Lower extremity weakness; Respiratory muscle weakness; Upper motor neuron signs; Muscle atrophy; Hyperreflexia; Steppage gait; Reduced pinprick sensation; Impaired vibratory sensation,Amyotrophic lateral sclerosis,"amyotrophic lateral sclerosis 1; als1,charcot-marie-tooth disease, axonal, type 2a1; cmt2a1,hereditary spastic paraplegia 4; spg4,charcot-marie-tooth disease, demyelinating, type 1a; cmt1a,spinal muscular atrophy, type iii; sma3,charcot-marie-tooth disease, axonal, type 2e; cmt2e,hereditary spastic paraplegia 3a; spg3a,charcot-marie-tooth disease, demyelinating, type 1b; cmt1b,hereditary spastic paraplegia 5a; spg5a,charcot-marie-tooth disease, axonal, type 2f; cmt2f","amyotrophic lateral sclerosis 1; als1,charcot-marie-tooth disease, axonal, type 2a1; cmt2a1,charcot-marie-tooth disease, type 1a; cmt1a,hereditary spastic paraplegia 4, autosomal dominant; spg4,charcot-marie-tooth disease, type 2e; cmt2e,charcot-marie-tooth disease, type 2f; cmt2f,charcot-marie-tooth disease, type 2k; cmt2k,charcot-marie-tooth disease, type 2l; cmt2l,charcot-marie-tooth disease, type 2n; cmt2n,charcot-marie-tooth disease, type 2o; cmt2o,charcot-marie-tooth disease, type 2p; cmt2p,charcot-marie-tooth disease, type 2q; cmt2q,charcot-marie-tooth disease, type 2r; cmt2r,charcot-marie-tooth disease, type 2s; cmt2s,charcot-marie-tooth disease, type 2t; cmt2t,charcot-marie-tooth disease, type 2u; cmt2u,charcot-marie-tooth disease, type 2v; cmt2v,charcot-marie-tooth disease, type 2w; cmt2w,charcot-marie-tooth disease, type 2x; cmt2x,charcot-marie-tooth disease, type 2y; cmt2y",1,1,"amyotrophic lateral sclerosis 1; als1,charcot-marie-tooth disease, axonal, type 2a1; cmt2a1,spinal muscular atrophy, distal, autosomal recessive, 1; dsma1,hereditary motor and sensory neuropathy, type iib; hmsn2b,spastic paraplegia 4, autosomal dominant; spg4,distal spinal muscular atrophy 2; dsma2,motor neuron disease, progressive, with or without ophthalmoplegia,spinal muscular atrophy, late-onset, finkel type; smafk,charcot-marie-tooth disease, axonal, type 2k; cmt2k,spastic paraplegia 3a, autosomal dominant; spg3a","amyotrophic lateral sclerosis 1; als1,spinal muscular atrophy, type i; sma1,charcot-marie-tooth disease, type 2a1; cmt2a1,hereditary motor and sensory neuropathy, type iib; hmsn2b,spastic paraplegia 4, autosomal dominant; spg4,distal spinal muscular atrophy, type v; dsma5,motor neuron disease, progressive, with upper and lower motor neuron involvement,spinal muscular atrophy, distal, autosomal recessive, 1; dsmar1,charcot-marie-tooth disease, axonal, type 2k; cmt2k,spastic paraplegia 3a, autosomal dominant; spg3a,hereditary motor and sensory neuropathy, type iia; hmsn2a,spinal muscular atrophy with respiratory distress 1; smard1,motor neuron disease, progressive, with upper and lower motor neuron dysfunction,charcot-marie-tooth disease, type 2f; cmt2f,spastic paraplegia 31; spg31,distal hereditary motor neuronopathy, type ii; dhmn2,spinal muscular atrophy, late-onset, finkel type; smafk,charcot-marie-tooth disease, axonal, type 2d; cmt2d,hereditary motor and sensory neuropathy, type vi; hmsn6,sp",1,1
Ptosis; Respiratory distress; Double vision; Limited upward eye movements; Bilateral ptosis; Deficit in the orbicularis of the eyelids,Congenital myasthenic syndrome type 19,"myasthenic syndrome, congenital, 1a, slow-channel; cms1a,myasthenic syndrome, congenital, 1b, fast-channel; cms1b,myasthenic syndrome, congenital, 2a, acetylcholine receptor deficiency; cms2a,myasthenic syndrome, congenital, 2c, acetylcholine receptor deficiency, adult onset; cms2c,myasthenic syndrome, congenital, 3a, primary acetylcholine deficiency; cms3a,myasthenic syndrome, congenital, 4a, presynaptic; cms4a,myasthenic syndrome, congenital, 5, presynaptic; cms5,myasthenic syndrome, congenital, 6, presynaptic; cms6,myasthenic syndrome, congenital, 7, presynaptic; cms7,myasthenic syndrome, congenital, 8, presynaptic; cms8","myasthenic syndrome, congenital, 1a, slow-channel; cms1a,myasthenic syndrome, congenital, 1b, fast-channel; cms1b,myasthenic syndrome, congenital, 2a, acetylcholine receptor deficiency; cms2a,myasthenic syndrome, congenital, 2c, acetylcholine receptor deficiency; cms2c,myasthenic syndrome, congenital, 3a, primary acetylcholinesterase deficiency; cms3a,myasthenic syndrome, congenital, 4a, slow-channel; cms4a,myasthenic syndrome, congenital, 5, fast-channel; cms5,myasthenic syndrome, congenital, 6, presynaptic; cms6,myasthenic syndrome, congenital, 7, presynaptic; cms7,myasthenic syndrome, congenital, 8, presynaptic; cms8,myasthenic syndrome, congenital, 9, presynaptic; cms9,myasthenic syndrome, congenital, 10, presynaptic; cms10,myasthenic syndrome, congenital, 11, presynaptic; cms11,myasthenic syndrome, congenital, 12, presynaptic; cms12,myasthenic syndrome, congenital, 13, presynaptic; cms13,myasthenic syndrome, congenital, 14, presynaptic; cms14,myasthenic syndrome, congenital, 15, presynaptic; cms15,myasthenic syndrome, congenital, 16, presynaptic; cms16,myasthenic syndrome, congenital, 17, presynaptic; cms17,myasthenic syndrome, congenital, 18, presynaptic; cms18",0,0,"myasthenic syndrome, congenital, 1a; cms1a,myasthenic syndrome, congenital, 2a; cms2a,myasthenic syndrome, congenital, 3a; cms3a,myasthenic syndrome, congenital, 4a; cms4a,myasthenic syndrome, congenital, 8; cms8,myasthenic syndrome, congenital, 10; cms10,mitochondrial myopathy with external ophthalmoplegia,progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1; peoa1,oculopharyngeal muscular dystrophy; opmd,kearns-sayre syndrome; kss","myasthenic syndrome, congenital, 1a; cms1a,myasthenic syndrome, congenital, 2a; cms2a,myasthenic syndrome, congenital, 3a; cms3a,myasthenic syndrome, congenital, 4a; cms4a,myasthenic syndrome, congenital, 8; cms8,myasthenic syndrome, congenital, 10; cms10,myasthenic syndrome, congenital, 11; cms11,mitochondrial myopathy with external ophthalmoplegia,progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 1; peoa1,chronic progressive external ophthalmoplegia,oculopharyngeal muscular dystrophy; opmd,oculopharyngodistal myopathy 1; opdm1,myopathy, centronuclear, 1; cnm1,kearns-sayre syndrome; kss,mitochondrial dna depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria); mtdps5,muscular dystrophy-dystroglycanopathy type a, 1; mddga1,myasthenia gravis with thymus hyperplasia; mgth,mitochondrial myopathy and sideroblastic anemia 1; mlasa1,ophthalmoplegia, external, with rrf,myopathy, mitochondrial progressive, with congen",0,0
Tremor; Dystonic posturing; Hoarse voice; Dysarthria; Swallowing difficulties; Torticollis; Axial dystonia; Opisthotonic posture; Dystonia,"Dystonia 1, torsion, autosomal dominant","dyt-tor1a dystonia,dyt-thap1 dystonia,dyt-gnal dystonia,dyt-kmt2b dystonia,dyt-ano3 dystonia,dyt-hpca dystonia,dyt-prkra dystonia,dyt-taf1 dystonia,dyt-atp1a3 dystonia,dyt-adcy5 dystonia","dyt-tor1a dystonia,dyt-thap1 dystonia,dyt-gnal dystonia,dyt-kmt2b dystonia,dyt-ano3 dystonia,dyt-hpca dystonia,dyt-prkra dystonia,dyt-taf1 dystonia,dyt-atp1a3 dystonia,dyt-adcy5 dystonia,dyt-ano3 dystonia,dyt-thap1 dystonia,dyt-ano3 dystonia,dyt-hpca dystonia,dyt-prkra dystonia,dyt-taf1 dystonia,dyt-atp1a3 dystonia,dyt-adcy5 dystonia,dyt-ano3 dystonia,dyt-thap1 dystonia",0,0,"dystonia 4, torsion; dyt4,dystonia 1, torsion; dyt1,dystonia 6, torsion; dyt6,dystonia-parkinsonism, early-onset; dytp,dystonia 28, childhood-onset; dyt28,dystonia 24; dyt24,dystonia 26; dyt26,dystonia 27; dyt27,combined dystonia and parkinsonism, x-linked; xdytp,rapid-onset dystonia-parkinsonism; rdp","dystonia 1, torsion, autosomal dominant; dyt1,dystonia 4, torsion, autosomal dominant; dyt4,dystonia 6, torsion, autosomal dominant; dyt6,dystonia-parkinsonism, rapid-onset; dyt12,dystonia, dopa-responsive; drd,dystonia, progressive, with marked orofacial involvement,dystonia, generalized, early-onset,dystonia-ataxia syndrome due to beta-propeller protein-associated neurodegeneration,neurodegeneration with brain iron accumulation 1; nbia1,wilson disease; wnd,dystonia-parkinsonism, x-linked; xdp,lubag syndrome,dystonia, juvenile-onset, with cerebellar atrophy,ataxia-telangiectasia; at,machado-joseph disease; mjd,huntington disease; hd,dystonia 3, torsion, x-linked; dyt3,dystonia 5, torsion; dyt5,neurodegeneration with brain iron accumulation 2a; nbia2a,dystonia-deafness syndrome; dds",0,1
Hypotonia; Motor delay; Speech delay; Intellectual disability; Autism; Visual-motor integration deficit; Stereotypic hand movements; Social withdrawal; Clumsy gait,White-Sutton syndrome,"rett syndrome,angelman syndrome,fragile x syndrome,pitt-hopkins syndrome,smith-magenis syndrome,prader-willi syndrome,mowat-wilson syndrome,rubinstein-taybi syndrome,williams-beuren syndrome,sanfilippo syndrome","rett syndrome,angelman syndrome,fragile x syndrome,pitt-hopkins syndrome,smith-magenis syndrome,prader-willi syndrome,williams syndrome,rubinstein-taybi syndrome,mowat-wilson syndrome,sanfilippo syndrome,jacobson syndrome,sotos syndrome,cohen syndrome,cornelia de lange syndrome,phelan-mcdermid syndrome,kabuki syndrome,lennard-jones syndrome,smith-lemli-opitz syndrome,wolf-hirschhorn syndrome,chromosome 22q11.2 deletion syndrome",0,0,"rett syndrome; rtt,mental retardation, autosomal dominant 54; mrd54,autism, susceptibility to, 1; auts1,developmental and epileptic encephalopathy 51; dee51,mental retardation, autosomal recessive 13; mrt13,angelman syndrome; as,phelan-mcdermid syndrome; phmds,christianson syndrome; chs,mental retardation, x-linked, syndromic, nascimento type; mrxsn,mental retardation, autosomal dominant 50; mrd50","rett syndrome; rtt,angelman syndrome; as,phelan-mcdermid syndrome; phmds,mental retardation, autosomal dominant 50; mrd50,autism, susceptibility to, 1; auts1,mental retardation, x-linked 102; mrx102,hypotonia, infantile, with psychomotor retardation and characteristic facies 1; ihprf1,christianson syndrome; csnk,mental retardation, autosomal recessive 13; mrt13,autism, susceptibility to, 18; auts18,mental retardation and distinctive facial features with or without cardiac defects,developmental delay with or without seizures and gait abnormalities,mental retardation, x-linked, syndromic 14; mrxs14,chromosome 2p16.1-p15 deletion syndrome,mental retardation, autosomal dominant 54; mrd54,hypotonia, infantile, with psychomotor retardation and characteristic facies 2; ihprf2,mental retardation, x-linked 30; mrx30,autism, susceptibility to, 15; auts15,mental retardation, autosomal recessive 62; mrt62,developmental and epileptic encephalopathy 51; dee51",0,0
Cognitive impairment; Ataxia; Dysarthria; Nystagmus; Tremor; Disorientation; Anomia; Acalculia; Apraxia; Visuospatial impairment,SPINOCEREBELLAR ATAXIA 17; SCA17,"spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 17; sca17,friedreich ataxia; frda,ataxia-telangiectasia; a-t,dentatorubral-pallidoluysian atrophy; drpla,ataxia with oculomotor apraxia type 1; aoa1","spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,spinocerebellar ataxia 17; sca17,friedreich ataxia; frda,ataxia-telangiectasia; a-t,ataxia with oculomotor apraxia type 1; aoa1,ataxia with oculomotor apraxia type 2; aoa2,dentatorubral-pallidoluysian atrophy; drpla,cerebellar ataxia, mental retardation, and dysmorphic facies; camrq1,spinocerebellar ataxia, autosomal recessive 1; scar1,spinocerebellar ataxia, autosomal recessive 2; scar2,spinocerebellar ataxia, autosomal recessive 3; scar3,spinocerebellar ataxia, autosomal recessive 4; scar4,spinocerebellar ataxia, autosomal recessive 5; scar5,spinocerebellar ataxia, autosomal recessive 6; scar6,spinocerebellar ataxia, autosomal recessive 7; scar7,spinocerebellar ataxia, autosomal recessive 8; scar8",1,1,"spinocerebellar ataxia 1; sca1,ataxia-telangiectasia; at,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1; camrq1,spinocerebellar ataxia 2; sca2,friedreich ataxia 1; frda,cerebellar ataxia, deafness, and narcolepsy, autosomal dominant; adcadn,niemann-pick disease, type c1; npc1,huntington disease; hd,spinocerebellar ataxia 3; sca3,cerebrotendinous xanthomatosis; ctx","spinocerebellar ataxia 1; sca1,spinocerebellar ataxia 2; sca2,spinocerebellar ataxia 3; sca3,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1; camrq1,ataxia-telangiectasia; at,friedreich ataxia 1; frda,cerebellar ataxia, deafness, and narcolepsy, autosomal dominant; adcadn,niemann-pick disease, type c1; npc1,wilson disease; wnd,huntington disease; hd,spinocerebellar ataxia 6; sca6,spinocerebellar ataxia 7; sca7,ataxia with vitamin e deficiency; aved,cerebrotendinous xanthomatosis; ctx,alexander disease; alxdrd,multiple system atrophy 1; msa1,fragile x-associated tremor/ataxia syndrome; fxtas,marinesco-sjogren syndrome; mss,ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia; eaoh,spinocerebellar ataxia 8; sca8",1,1
Deafness; Myoclonic epilepsy; Muscle weakness; Retinitis pigmentosa; Ataxia; Cerebellar atrophy; Hypogonadism; Hypothyroidism; Adrenal insufficiency; Short stature,"NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA","mitochondrial dna depletion syndrome 7 (mngie type),kallmann syndrome 1,wolfram syndrome 1,refsum disease,cockayne syndrome b,alstrom syndrome,bardet-biedl syndrome 1,spinocerebellar ataxia 36,peroxisome biogenesis disorder 1a (zellweger),leigh syndrome","alstrom syndrome,cohen syndrome,kallmann syndrome 1,kallmann syndrome 2,kallmann syndrome 3,kallmann syndrome 4,kallmann syndrome 5,kallmann syndrome 6,kallmann syndrome 7,kallmann syndrome 8,kallmann syndrome 9,kallmann syndrome 10,kallmann syndrome 11,kallmann syndrome 12,kallmann syndrome 13,kallmann syndrome 14,kallmann syndrome 15,kallmann syndrome 16,kallmann syndrome 17,kallmann syndrome 18",0,0,"wolfram syndrome 1; wfs1,mitochondrial dna depletion syndrome 7; mtdps7,perrault syndrome 1; prlts1,alstrom syndrome; alms,refsum disease, classic; rd,kearns-sayre syndrome; kss,mitochondrial encephalopathy with lactic acidosis and stroke-like episodes; melas,marinesco-sjogren syndrome; mss,progressive external ophthalmoplegia with mitochondrial dna deletions 1; peoa1,leigh syndrome; ls","wolfram syndrome 1; wfs1,mitochondrial dna depletion syndrome 7; mtdps7,perrault syndrome 1; prlts1,alstrom syndrome; alms,refsum disease, classic; rd,marinesco-sjogren syndrome; mss,mitochondrial encephalopathy with lactic acidosis and stroke-like episodes; melas,kearns-sayre syndrome; kss,progressive external ophthalmoplegia with mitochondrial dna deletions 1; peoa1,richards-rundle syndrome; rrsy,perrault syndrome 2; prlts2,perrault syndrome 3; prlts3,mitochondrial dna depletion syndrome 5; mtdps5,spinocerebellar ataxia, autosomal recessive 28; scar28,cerebellar ataxia, deafness, and narcolepsy, autosomal dominant; adcadn,mitochondrial complex i deficiency, nuclear type 22; mc1dn22,coenzyme q10 deficiency, primary, 4; coq10d4,mitochondrial dna depletion syndrome 13; mtdps13,ataxia-pancytopenia syndrome; atxpc,cerebellar ataxia, deafness, and narcolepsy, autosomal recessive; cadn",0,0
Microcephaly; Neonatal hypotonia; Seizures; Profound developmental delay; Dysmorphic features; Hypertelorism; Micro retrognathia; Feeding difficulties; Failure to thrive; Central hypotonia,"Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO)-like syndrome","microcephaly, seizures, and developmental delay; mcsz,microcephaly, congenital cataract, and psychomotor retardation; mccrp,microcephaly, epilepsy, and diabetes syndrome; meds,microcephaly, epilepsy, and diabetes syndrome 2; meds2,microcephaly, epilepsy, and developmental delay; medd,microcephaly, progressive, with seizures and cortical atrophy; mpsca,microcephaly, progressive, with seizures and brain atrophy; mpsba,microcephaly, congenital, and severe developmental delay; mcsdd,microcephaly, epilepsy, and cortical malformations; mecm,microcephaly, severe, with seizures and cerebral and cerebellar atrophy; msscca","microcephaly, seizures, and developmental delay; mcsz,microcephaly, congenital cataract, and psychomotor retardation; mccrp,microcephaly, epilepsy, and diabetes syndrome; meds,microcephaly, epilepsy, and diabetes syndrome 2; meds2,microcephaly, epilepsy, and developmental delay; medd,microcephaly, progressive, with seizures and cortical atrophy; mpsca,microcephaly, progressive, with seizures and brain atrophy; mpsba,microcephaly, congenital, and severe developmental delay; mcsdd,microcephaly, severe, with seizures and cerebellar atrophy; mssca,microcephaly, severe, with seizures and cortical malformations; msscm,microcephaly, severe, with seizures and developmental delay; mssdd,microcephaly, severe, with seizures and hypotonia; mssh,microcephaly, severe, with seizures and spasticity; msss,microcephaly, severe, with seizures and white matter abnormalities; msswma,microcephaly, severe, with seizures, developmental delay, and hypotonia; mssddh,microcephaly, severe, with seizures, developmental delay, and spasticity; mssdds,microcephaly, severe, with seizures, developmental delay, and white matter abnormalities; mssddwma,microcephaly, severe, with seizures, hypotonia, and spasticity; msshs,microcephaly, severe, with seizures, hypotonia, and white matter abnormalities; msshwma,microcephaly, severe, with seizures, spasticity, and white matter abnormalities; mssswma",0,0,"developmental and epileptic encephalopathy 95; dee95,microcephaly, seizures, and developmental delay; mcsz,pontocerebellar hypoplasia, type 4; pch4,developmental and epileptic encephalopathy 85; dee85,microcephaly-hypotonia-seizure syndrome-3; mhss3,neurodevelopmental disorder with microcephaly, hypotonia, and seizures; nedhms,epileptic encephalopathy, early infantile, 3; eiee3,developmental and epileptic encephalopathy 90; dee90,microcephaly, progressive, with seizures and cerebral and cerebellar atrophy; mscca,developmental and epileptic encephalopathy 28; dee28","developmental and epileptic encephalopathy 95; dee95,microcephaly, seizures, and developmental delay; mcsz,pontocerebellar hypoplasia, type 4; pch4,developmental and epileptic encephalopathy 85; dee85,microcephaly 16, primary, autosomal recessive; mcph16,developmental and epileptic encephalopathy 28; dee28,epileptic encephalopathy, early infantile, 3; eiee3,developmental and epileptic encephalopathy 90; dee90,neurodevelopmental disorder with microcephaly and epilepsy; nedme,pontocerebellar hypoplasia, type 1; pch1,developmental and epileptic encephalopathy 31; dee31,microcephaly, progressive, with seizures and cerebral and cerebellar atrophy; mscca,developmental and epileptic encephalopathy 89; dee89,neurodevelopmental disorder with hypotonia and cerebellar atrophy; nedhca,developmental and epileptic encephalopathy 82; dee82,microcephaly 19, primary, autosomal recessive; mcph19,developmental and epileptic encephalopathy 86; dee86,hypotonia, infantile, with psychomotor retardation and characteristic facies 1; ihprf1,developmental and epileptic encephalopathy 87; dee87,neurodevelopmental disorder with microcephaly and hypotonia; nedmh",0,0
Calf hypertrophy; Fatigability; Limb-girdle weakness; Jaw weakness; Neck drop; Bifacial weakness; Truncal weakness; Exertional breathlessness,Congenital Myasthenic Syndrome,"facioscapulohumeral muscular dystrophy 1; fshd1,limb-girdle muscular dystrophy, autosomal dominant 1; lgmd1a,limb-girdle muscular dystrophy, autosomal recessive 1; lgmd2a,myotonic dystrophy 1; dm1,emery-dreifuss muscular dystrophy 1, x-linked; emd1,bethlem myopathy 1; bthlm1,congenital myasthenic syndrome 1a; cms1a,charcot-marie-tooth disease, axonal, type 2a1; cmt2a1,dystrophinopathy,myofibrillar myopathy 1; mfm1","myotonic dystrophy 1; dm1,myotonic dystrophy 2; dm2,facioscapulohumeral muscular dystrophy 1; fshd1,facioscapulohumeral muscular dystrophy 2; fshd2,limb-girdle muscular dystrophy, autosomal dominant 1; lgmd1a,limb-girdle muscular dystrophy, autosomal dominant 2; lgmd1b,limb-girdle muscular dystrophy, autosomal dominant 3; lgmd1c,limb-girdle muscular dystrophy, autosomal dominant 4; lgmd1d,limb-girdle muscular dystrophy, autosomal dominant 5; lgmd1e,limb-girdle muscular dystrophy, autosomal dominant 6; lgmd1f,limb-girdle muscular dystrophy, autosomal dominant 7; lgmd1g,limb-girdle muscular dystrophy, autosomal dominant 8; lgmd1h,limb-girdle muscular dystrophy, autosomal dominant 9; lgmd1i,limb-girdle muscular dystrophy, autosomal dominant 10; lgmd1j,limb-girdle muscular dystrophy, autosomal dominant 11; lgmd1k,limb-girdle muscular dystrophy, autosomal dominant 12; lgmd1l,limb-girdle muscular dystrophy, autosomal dominant 13; lgmd1m,limb-girdle muscular dystrophy, autosomal dominant 14; lgmd1n,limb-girdle muscular dystrophy, autosomal dominant 15; lgmd1o,limb-girdle muscular dystrophy, autosomal dominant 16; lgmd1p",1,0,"limb-girdle muscular dystrophy 2i; lgmd2i,myasthenia gravis, familial; mgfa,muscular dystrophy, congenital, fukuyama type; fcmd,myasthenic syndrome, congenital, 1a; cms1a,muscular dystrophy, limb-girdle, type 2a; lgmd2a,myopathy, centronuclear, 1; cnm1,muscular dystrophy, duchenne type; dmd,myopathy, myofibrillar, 1; mfm1,muscular dystrophy, becker type; bmd,myasthenic syndrome, congenital, 2a; cms2a","limb-girdle muscular dystrophy 2i; lgmd2i,myasthenia gravis; mg,muscular dystrophy, duchenne type; dmd,muscular dystrophy, becker type; bmd,limb-girdle muscular dystrophy 2a; lgmd2a,myasthenic syndrome, congenital, 1a; cms1a,limb-girdle muscular dystrophy 2b; lgmd2b,myopathy, centronuclear, 1; cnm1,glycogen storage disease ii; gsd2,myopathy, myofibrillar, 1; mfm1,muscular dystrophy-dystroglycanopathy type c1; mddgc1,emery-dreifuss muscular dystrophy 1; edmd1,myopathy, distal, with anterior tibial onset; mpdt,nemaline myopathy 1; nem1,limb-girdle muscular dystrophy 2d; lgmd2d,myasthenic syndrome, congenital, 2a; cms2a,muscular dystrophy, congenital, 1a; mdc1a,myopathy, centronuclear, x-linked; cnmx,limb-girdle muscular dystrophy 2e; lgmd2e,myopathy with early respiratory failure; merf",0,0
Developmental delay; Epilepsy; Neurological developmental impairment; Severe malnutrition; Feeding difficulty; Congenital heart disease; Recurrent pneumonia,Epileptic encephalopathy,"dravet syndrome,pitt-hopkins syndrome,cdkl5 deficiency disorder,foxg1 syndrome,sturge-weber syndrome,tuberous sclerosis 1,angelman syndrome,rett syndrome,phelan-mcdermid syndrome,wolf-hirschhorn syndrome","dravet syndrome,angelman syndrome,rett syndrome,tuberous sclerosis 1; tsc1,tuberous sclerosis 2; tsc2,pitt-hopkins syndrome,cdkl5 deficiency disorder,foxg1 syndrome,mecp2 duplication syndrome,phelan-mcdermid syndrome,sturge-weber syndrome,aicardi syndrome,west syndrome,lennox-gastaut syndrome,wolf-hirschhorn syndrome,jacobson syndrome,smith-magenis syndrome,mowat-wilson syndrome,cohen syndrome,kabuki syndrome",0,0,"developmental and epileptic encephalopathy 28; dee28,epileptic encephalopathy, early infantile, 13; eiee13,developmental and epileptic encephalopathy 85; dee85,chromosome 1p36 deletion syndrome,angelman syndrome; as,pitt-hopkins syndrome; pths,developmental and epileptic encephalopathy 5; dee5,rett syndrome; rtt,dravet syndrome,developmental and epileptic encephalopathy 31; dee31","developmental and epileptic encephalopathy 1; dee1,epileptic encephalopathy, early infantile, 2; eiee2,developmental and epileptic encephalopathy 5; dee5,angelman syndrome; as,rett syndrome; rtt,pitt-hopkins syndrome; pths,dravet syndrome,developmental and epileptic encephalopathy 6; dee6,cerebral palsy, spastic quadriplegic, 1; cpsq1,epileptic encephalopathy, early infantile, 13; eiee13,developmental and epileptic encephalopathy 4; dee4,chromosome 1p36 deletion syndrome,mowat-wilson syndrome; mows,developmental and epileptic encephalopathy 8; dee8,christianson syndrome,developmental and epileptic encephalopathy 28; dee28,kohlschutter-tonz syndrome; ktzs,west syndrome,developmental and epileptic encephalopathy 33; dee33,mecp2 duplication syndrome",1,1
Developmental delay; Speech and language difficulties; Frequent falls; Mild hypotonia; Ataxia; Loss of sphincter control; Expressive and receptive language regression; Cerebellar syndrome; Severe intellectual disability,Childhood neurodegeneration associated with UBTF c.628G>A variant,"angelman syndrome,ataxia-telangiectasia,spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2; scar2,fragile x syndrome,rett syndrome,pontocerebellar hypoplasia, type 1a; pch1a,jouett syndrome,spinocerebellar ataxia, autosomal recessive, 14; scar14,coffin-lowry syndrome,spinocerebellar ataxia, autosomal recessive, 13; scar13","angelman syndrome,ataxia-telangiectasia,fragile x syndrome,rett syndrome,spinocerebellar ataxia type 1,spinocerebellar ataxia type 2,spinocerebellar ataxia type 3,spinocerebellar ataxia type 6,spinocerebellar ataxia type 7,spinocerebellar ataxia type 17,jou bert syndrome 1,jou bert syndrome 2,jou bert syndrome 3,jou bert syndrome 4,jou bert syndrome 5,jou bert syndrome 6,jou bert syndrome 7,jou bert syndrome 8,jou bert syndrome 9,jou bert syndrome 10",0,0,"cerebellar ataxia, developmental delay, and seizures; caddys,pontocerebellar hypoplasia, type 1b; pch1b,spinocerebellar ataxia, autosomal recessive 7; scar7,cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3; camrq3,ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia; eaoh,mental retardation, autosomal recessive 13; mrt13,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1; camrds1,spastic ataxia 5, autosomal recessive; spax5,developmental and epileptic encephalopathy 89; dee89,cerebellar ataxia and hypogonadism; cahyd","cerebellar ataxia, developmental delay, and seizures; caddys,pontocerebellar hypoplasia, type 1b; pch1b,spinocerebellar ataxia, autosomal recessive 7; scar7,cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3; camrq3,ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia; eaoh,mental retardation, autosomal recessive 13; mrt13,cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1; camrds1,spastic paraplegia 79, autosomal recessive; spg79,pontocerebellar hypoplasia, type 2a; pch2a,ataxia-telangiectasia; at,joubert syndrome 2; jbts2,mental retardation, autosomal recessive 54; mrt54,cerebellar ataxia and hypogonadism with or without oculomotor apraxia; cahoma,spinocerebellar ataxia, autosomal recessive 8; scar8,cerebellar ataxia, developmental delay, and seizures 2; caddys2,pontocerebellar hypoplasia, type 4; pch4,mental retardation, autosomal recessive 31; mrt31,cerebellar ataxia and mental retardation with or without quadrupedal locomotion 1; camrq1,spinocere",0,0
"Bilateral, painless subacute failure of central vision; Loss of colour vision affecting mostly the red-green system; Dense central or centrocecal scotoma; Reduced contrast sensitivity; Postural tremor; Peripheral neuropathies; Movement disorders",Leber hereditary optic neuropathy,"leber hereditary optic neuropathy; lhon,charcot-marie-tooth disease, type 2a1; cmt2a1,charcot-marie-tooth disease, type 2a2; cmt2a2,charcot-marie-tooth disease, type 2b1; cmt2b1,charcot-marie-tooth disease, type 2b2; cmt2b2,charcot-marie-tooth disease, type 2c; cmt2c,charcot-marie-tooth disease, type 2d; cmt2d,charcot-marie-tooth disease, type 2e; cmt2e,charcot-marie-tooth disease, type 2f; cmt2f,charcot-marie-tooth disease, type 2g; cmt2g","leber hereditary optic neuropathy; lhon,charcot-marie-tooth disease, type 2a1; cmt2a1,charcot-marie-tooth disease, type 2a2; cmt2a2,charcot-marie-tooth disease, type 2b1; cmt2b1,charcot-marie-tooth disease, type 2b2; cmt2b2,charcot-marie-tooth disease, type 2c; cmt2c,charcot-marie-tooth disease, type 2d; cmt2d,charcot-marie-tooth disease, type 2e; cmt2e,charcot-marie-tooth disease, type 2f; cmt2f,charcot-marie-tooth disease, type 2g; cmt2g,charcot-marie-tooth disease, type 2h; cmt2h,charcot-marie-tooth disease, type 2i; cmt2i,charcot-marie-tooth disease, type 2j; cmt2j,charcot-marie-tooth disease, type 2k; cmt2k,charcot-marie-tooth disease, type 2l; cmt2l,charcot-marie-tooth disease, type 2m; cmt2m,charcot-marie-tooth disease, type 2n; cmt2n,charcot-marie-tooth disease, type 2o; cmt2o,charcot-marie-tooth disease, type 2p; cmt2p,charcot-marie-tooth disease, type 2q; cmt2q",1,1,"leber hereditary optic neuropathy; lhon,optic atrophy 1; opa1,mitochondrial dna depletion syndrome 4b (mngie type); mtdps4b,hereditary motor and sensory neuropathy via; hmsn6a,optic atrophy plus syndrome; opa1plus,wolfram syndrome 1; wfs1,charcot-marie-tooth disease, axonal, type 2a2a; cmt2a2a,mitochondrial dna depletion syndrome 8a; mtdps8a,optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy; oaodan,hereditary sensory and autonomic neuropathy type ib; hsan1b","leber hereditary optic neuropathy; lhon,optic atrophy 1; opa1,mitochondrial dna depletion syndrome 4b (mngie type); mtdps4b,hereditary motor and sensory neuropathy via; hmsn6a,optic atrophy plus syndrome; opa1plus,charcot-marie-tooth disease, type 2a1; cmt2a1,mitochondrial dna depletion syndrome 8a; mtdps8a,wolfram syndrome 1; wfs1,optic atrophy 3; opa3,spinocerebellar ataxia 1; sca1,multiple mitochondrial dysfunctions syndrome 5; mmds5,leigh syndrome; ls,friedreich ataxia 1; frda1,mitochondrial complex i deficiency, nuclear type 22; mc1dn22,dominant optic atrophy and deafness; adoad,multiple system atrophy 1; msa1,optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy,mitochondrial dna depletion syndrome 13 (encephalomyopathic type); mtdps13,hereditary sensory and autonomic neuropathy type 1; hsan1,mitochondrial encephalopathy with lactic acidosis and stroke-like episodes; melas",1,1
Sensorineural hearing impairment; Visual field defect; Stroke-like episodes; Short stature; Seizures,"MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS","mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes; melas,mitochondrial dna depletion syndrome 12a (transcriptome), infantile-onset; mtdps12a,mitochondrial dna depletion syndrome 12b (transcriptome), adult-onset; mtdps12b,mitochondrial complex iii deficiency, nuclear type 1; mc3dn1,mitochondrial complex iii deficiency, nuclear type 2; mc3dn2,mitochondrial complex iii deficiency, nuclear type 3; mc3dn3,mitochondrial complex iii deficiency, nuclear type 4; mc3dn4,mitochondrial complex iii deficiency, nuclear type 5; mc3dn5,mitochondrial complex iii deficiency, nuclear type 6; mc3dn6,mitochondrial complex iii deficiency, nuclear type 7; mc3dn7","mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes; melas,mitochondrial dna-related hearing loss and deafness,mitochondrial complex i deficiency,mitochondrial complex iii deficiency; mc3dn1,mitochondrial complex iv deficiency; mc4dn1,mitochondrial complex v deficiency, nuclear type 1; mc5dn1,mitochondrial neurogastrointestinal encephalomyopathy; mngie,mitochondrial dna depletion syndrome 1 (mngie type); mtdps1,mitochondrial dna depletion syndrome 2 (myopathic type); mtdps2,mitochondrial dna depletion syndrome 3 (hepatic type); mtdps3,mitochondrial dna depletion syndrome 4a (alpers type); mtdps4a,mitochondrial dna depletion syndrome 4b (mngie type); mtdps4b,mitochondrial dna depletion syndrome 5 (encephalomyopathic type); mtdps5,mitochondrial dna depletion syndrome 6 (hepatic type); mtdps6,mitochondrial dna depletion syndrome 7 (hepatic type); mtdps7,mitochondrial dna depletion syndrome 8 (encephalomyopathic type); mtdps8,mitochondrial dna depletion syndrome 9 (encephalomyopathic type); mtdps9,mitochondrial dna depletion syndrome 10 (hepatic type); mtdps10,mitochondrial dna depletion syndrome 11 (encephalomyopathic type); mtdps11,mitochondrial dna depletion syndrome 12 (hepatic type); mtdps12",1,1,"mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes; melas,wolfram syndrome 1; wfs1,leigh syndrome; ls,alpers-huttenlocher syndrome; ahs,neuropathy, ataxia, and retinitis pigmentosa; narp,deafness-dystonia-optic neuronopathy syndrome; ddon,mitochondrial dna depletion syndrome 7; mtdps7,perrault syndrome 1; prlts1,cockayne syndrome type a; csa,kearns-sayre syndrome; kss","mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes; melas,wolfram syndrome 1; wfs1,leigh syndrome; ls,alpers-huttenlocher syndrome; ahs,myoclonic epilepsy with ragged red fibers; merrf,neuropathy, ataxia, and retinitis pigmentosa; narp,deafness-dystonia-optic neuronopathy syndrome; ddon,perrault syndrome 1; prlts1,mitochondrial dna depletion syndrome 7; mtdps7,progressive external ophthalmoplegia with mitochondrial dna deletions 1; peoa1,deafness, autosomal dominant 1; dfna1,usher syndrome, type 1b; ush1b,cockayne syndrome type a; csa,neurodegeneration with brain iron accumulation 1; nbia1,mitochondrial dna depletion syndrome 13; mtdps13,pontocerebellar hypoplasia, type 6; pch6,mitochondrial complex iii deficiency, nuclear type 1; mc3dn1,combined oxidative phosphorylation deficiency 1; coxpd1,deafness, autosomal recessive 12; dfnb12,mitochondrial short-chain enoyl-coa hydratase 1 deficiency; echs1d",1,1
Tonic seizures; Epileptic spasms; Focal seizures; Developmental delay; Bilateral gaze; Teeth biting; Right limb convulsions; Head nodding; Flexion of upper limbs,Familial focal epilepsy with variable foci,"epileptic encephalopathy, early infantile, 1; eiee1,epileptic encephalopathy, early infantile, 2; eiee2,epileptic encephalopathy, early infantile, 3; eiee3,epileptic encephalopathy, early infantile, 4; eiee4,epileptic encephalopathy, early infantile, 5; eiee5,epileptic encephalopathy, early infantile, 6; eiee6,epileptic encephalopathy, early infantile, 7; eiee7,epileptic encephalopathy, early infantile, 8; eiee8,epileptic encephalopathy, early infantile, 9; eiee9,epileptic encephalopathy, early infantile, 10; eiee10","epileptic encephalopathy, early infantile, 1; eiee1,epileptic encephalopathy, early infantile, 2; eiee2,epileptic encephalopathy, early infantile, 3; eiee3,epileptic encephalopathy, early infantile, 4; eiee4,epileptic encephalopathy, early infantile, 5; eiee5,epileptic encephalopathy, early infantile, 6; eiee6,epileptic encephalopathy, early infantile, 7; eiee7,epileptic encephalopathy, early infantile, 8; eiee8,epileptic encephalopathy, early infantile, 9; eiee9,epileptic encephalopathy, early infantile, 10; eiee10,epileptic encephalopathy, early infantile, 11; eiee11,epileptic encephalopathy, early infantile, 12; eiee12,epileptic encephalopathy, early infantile, 13; eiee13,epileptic encephalopathy, early infantile, 14; eiee14,epileptic encephalopathy, early infantile, 15; eiee15,epileptic encephalopathy, early infantile, 16; eiee16,epileptic encephalopathy, early infantile, 17; eiee17,epileptic encephalopathy, early infantile, 18; eiee18,epileptic encephalopathy, early infantile, 19; eiee19,epileptic encephalopathy, early infantile, 20; eiee20",0,0,"epileptic encephalopathy, early infantile, 1; eiee1,epileptic encephalopathy, early infantile, 2; eiee2,epileptic encephalopathy, early infantile, 4; eiee4,epileptic encephalopathy, early infantile, 6; eiee6,developmental and epileptic encephalopathy 85; dee85,developmental and epileptic encephalopathy 28; dee28,epilepsy, focal, with speech disorder and with or without mental retardation; fesd,west syndrome, x-linked, 1; wssx1,developmental and epileptic encephalopathy 54; dee54,epileptic encephalopathy, early infantile, 25; eiee25","epileptic encephalopathy, early infantile, 1; eiee1,epileptic encephalopathy, early infantile, 2; eiee2,epileptic encephalopathy, early infantile, 4; eiee4,epileptic encephalopathy, early infantile, 6; eiee6,epileptic encephalopathy, early infantile, 7; eiee7,developmental and epileptic encephalopathy 85; dee85,developmental and epileptic encephalopathy 89; dee89,developmental and epileptic encephalopathy 95; dee95,west syndrome, x-linked; wsyx,epilepsy, focal, with speech disorder and with or without mental retardation,developmental and epileptic encephalopathy 54; dee54,developmental and epileptic encephalopathy 5; dee5,epileptic encephalopathy, early infantile, 25; eiee25,developmental and epileptic encephalopathy 27; dee27,developmental and epileptic encephalopathy 33; dee33,epilepsy, progressive myoclonic, 1a; epm1a,developmental and epileptic encephalopathy 51; dee51,developmental and epileptic encephalopathy 72; dee72,developmental and epileptic encephalopathy 84; dee84,epileptic encephalopathy, early infantile, 14; eiee14",0,0
,,,,21,19,,,22,26
,,,,0.355932203,0.322033898,,,0.372881356,0.440677966